Identification of the Circadian Synaptic Transcriptome and the Role of DBHS Proteins in Synaptic Biology by Mircsof, Dennis
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2015
Identification of the Circadian Synaptic Transcriptome and the Role of
DBHS Proteins in Synaptic Biology
Mircsof, Dennis
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-121289
Dissertation
Published Version
Originally published at:
Mircsof, Dennis. Identification of the Circadian Synaptic Transcriptome and the Role of DBHS Proteins
in Synaptic Biology. 2015, University of Zurich, Faculty of Science.
Identification of the Circadian Synaptic Transcriptome 
and the Role of DBHS Proteins in Synaptic Biology 
 
 
Dissertation 
 zur  
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.)  
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät  
der  
Universität Zürich  
von 
 Dennis Mircsof  
von 
Gossau, SG 
 
Promotionskomitee 
Prof. Dr. Jean-Marc Fritschy (Vorsitz)  
Prof. Dr. Steven A. Brown (Leitung der Dissertation) 
Prof. Dr. Michael Kiebler 
Prof. Dr. Stephan Neuhauss 
 
Zürich, 2015 
 
 
 
 
 
 
 
 
 
 
 
 
! !
!
Table&of&Contents!
!
Table of Contents !
Abstract(..................................................................................................................(I&
Zusammenfassung(................................................................................................(III&
1.(General(Introduction(..........................................................................................(1(
&
1.1&Circadian&Clocks&..............................................................................................................&1&
1.2&Concept&of&Biological&Clocks&...........................................................................................&1&
1.3&Molecular&Basis&of&Circadian&Clocks&................................................................................&2&
1.4&Master&and&Peripheral&Clocks&.........................................................................................&5&
1.5&Clock&Genes&In&The&Hippocampus&...................................................................................&5&
1.6&Circadian&Rhythms&And&Memory&....................................................................................&8&
1.6&Organization&Of&The&Inhibotory&GABAergic&Synapse&....................................................&13&
1.7&NONO&–&A&Link&between&Circadian&Rhythms&And&Memory?&.........................................&18&
2.(Aims(of(the(Thesis(............................................................................................(21&
3.(Results(.............................................................................................................(23(
&
Study(I:(Identification(of(the(Circadian(Synaptic(Transcriptome&......................................&23&
Abstract&...............................................................................................................................&24&
Introduction&........................................................................................................................&24&
Results&.................................................................................................................................&26&
Discussion&...........................................................................................................................&29&
Material&and&Methods&........................................................................................................&31&
References&..........................................................................................................................&33&
&
Study(II:(The(Role(of(DBHS(Proteins(in(Regulating(Inhibitory(Synapse(Structure&.............&35&
Abstract&...............................................................................................................................&36&
Introduction&........................................................................................................................&37&
Results&.................................................................................................................................&38&
Discussion&...........................................................................................................................&49&
Material&and&Methods&........................................................................................................&51&
References&..........................................................................................................................&53&
Table&of&Contents!
&
& & &
&
Study(III:(NONO(mutations(are(a(novel(cause(of(syndromic(intellectual(disability(and(
inhibitory(synaptic(defects&.................................................................................................&57&
Abstract&...............................................................................................................................&58&
Results&.................................................................................................................................&58&
Discussion&...........................................................................................................................&63&
Acknowledgements&.............................................................................................................&63&
Author&Contributions&..........................................................................................................&64&
References&..........................................................................................................................&65&
Online&Methods&..................................................................................................................&73&
Supplementary&Information&................................................................................................&87&
4.(General(Discussion(.........................................................................................(105&
5.(Acknowledgements(........................................................................................(111&
6.(List(of(Abbreviations(.......................................................................................(113&
7.(References(.....................................................................................................(115&
8.(Curriculum(Vitae(............................................................................................(131&
&
 
 
& & Abstract!
&
& & &I!
Abstract 
 
Circadian rhythms are intrinsic oscillations, which occur periodically over the 
course of 24 hours and are conserved in many biological systems ranging 
from simple algae to complex organisms such as humans. These rhythms 
allow better anticipation of environmental changes such as the light-dark cycle 
or temperature fluctuations. It has been demonstrated that circadian clocks 
modulate daily changes of a variety of biological processes such as body 
temperature, hormone secretion, blood pressure, metabolism and many other 
functions. Interestingly, an increasing number of studies have demonstrated 
that alteration in the circadian system affect learning and memory 
consolidation. The biological basis of learning and memory is mainly regulated 
by synaptic plasticity through molecular mechanisms known as Long Term 
Potentiation (LTP) and Long Term Depression (LTD) and it has been shown 
that these forms of synaptic modifications require de-novo protein synthesis. 
Over the past few decades studies have demonstrated that the underlying 
protein translation in dendrites takes place in a small and localized 
compartment near the remodeling synapses by utilizing synaptic mRNA. Most 
of the studies that focused on mRNA dynamics at the synapse have been 
limited to the process of development or very short time periods during 
synapse activation. However, possible circadian dynamics in synaptic mRNAs 
has not been investigated so far, especially given the fact that learning and 
memory consolidation are regulated in a circadian fashion.  
Therefore, the first goal of my thesis was to understand the possible role of 
circadian regulation of the local synaptic mRNA. By the implementation of 
biochemical isolation of synaptic nerve terminals called synaptosmomes and 
using next-generation sequencing of synaptosomal preparations, I could 
identify a total of 900 rhythmic expressed genes in the mouse brain and 180 
rhythmic synaptic transcripts. Interestingly, I observed very poor overlap 
between these populations of rhythmic mRNA indicating that oscillations of 
mRNA at the synapse are independent of the nuclear circadian transcription 
process. 
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Synaptic mRNA transcripts are transported by neuronal RNA granules along 
microtubules control local protein synthesis in response to synaptic activity. 
Among these proteins two RNA-binding proteins namely NONO and SFPQ 
which belong to the DBHS family have been described to be components of 
RNA transport granules. Interestingly, these proteins are also linked to the 
circadian system. The role of NONO and other DBHS proteins such as SPFQ 
and PSPC1 in transcription and circadian clock regulation is very well known. 
However, their possible function in synapse morphology is up to now unclear.  
In the second part of my thesis, I demonstrated that NONO and PSPC1 
modulate inhibitory post-synaptic structures of gephyrin and GABAA receptor 
α2 both in-vitro as well in-vivo using a mouse model deficient of the 
corresponding protein. Interestingly NONO and PSPC1 knockout mice exhibit 
opposite gephyrin and GABAA receptor α2 morphology as well GABRA2 
mRNA levels. In addition, I could show that disrupting paraspeckles by 
depletion of the long-noncoding nuclear RNA Neat1 dramatically increases 
gephyrin and GABAA receptor α2 clustering in the mouse hippocampus.  
To understand in detail the functional consequences of these morphological 
changes I used NONO deficient mice as a model. I could demonstrate that 
NONO deficient mice exhibit craniofacial anomalies as well as global 
transcriptional dysregulation in fibroblasts and hippocampal tissue. 
Behaviorally, mice showed impaired performance in the Morris Water Maze 
as well as a marked anxiety phenotype documented via prepulse inhibition, 
open field exploration and light-dark preference testing. This results are 
strongly supported by the finding that null mutations in the NONO gene in 
humans are a novel cause of X-linked syndromic intellectual disability 
characterized by facial features as well as shy, gentle and cheerful behavior. 
These observations highlight for the first time the key role of a DBHS protein 
in learning and memory and the role of DBHS proteins in the functional 
organization of GABAergic synapses. 
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Zusammenfassung 
 
Zirkadiane Rhythmen sind intrinsisch Oszillationen, die in regelmässigen 
Abständen über den Verlauf von 24 Stunden auftreten und sind in vielen 
biologischen Systemen welche von einfachen Algen über komplexere 
Organismen wie zum Beispiel den Menschen reichen konserviert. Diese 
natürliche Rhythmen erlauben die Antizipation von täglichen 
Umweltschwankungen, wie den hell-dunkel Zyklus oder Temperatur-
schwankungen und es wurde gezeigt, dass diese Schwingungen in einer 
Vielzahl von biologischen Prozessen, wie Körpertemperatur, Hormon-
sekretion, Blutdruck, Stoffwechsel und viele anderen Funktionen beteiligt sind. 
Darüber hinaus haben immer mehr wissenschaftliche Studien gezeigt, dass 
Veränderungen im zirkadianen System das Lernen und Gedächtnis 
beeinflussen. Die biologische Basis für Lernen und Gedächtnis ist 
hauptsächlich durch synaptische Plastizität geregelt welche den molekularen 
Mechanismen wie Langzeit-Potenzierung (LTP) und Langzeit-Depression 
(LTD) unterliegt und es hat sich gezeigt, dass diese Formen der synaptischen 
Änderungen von Grund auf neue Proteinsynthese erfordern. In den letzten 
Jahrzehnten haben Studien gezeigt, dass die zugrunde liegende 
Proteintranslation in Dendriten in einer kleinen und lokalisierten Weise direkt 
neben der umgestaltenden Synapsen durch die Verwendung von 
synaptischer mRNA stattfindet. Obwohl diese mRNA Dynamik an der 
Synapse während der Entwicklung von Organismen und sehr kurze 
Zeiträume während Synapsen-Aktivierung bereits untersucht wurden, ist die 
zirkadiane Dynamik der synaptischen mRNAs über einen Zeitraum von 24 
Stunden noch nicht erforscht, vor allem angesichts der Tatsache, dass Lernen 
und Gedächtnis einem zirkadianen Prozess unterliegen. 
 
In dieser Arbeit beschreiben wir die Identifikation der zirkadianen 
synaptischen Transkripte im Maushirn durch die Implementierung der 
biochemischen Isolierung von synaptischen Nervenendigungen (genannt 
Synaptosomen). „Next-Generation-Sequencing“ (NGS) von Synaptosomen 
identifizierte 900 rhythmisch exprimierte Gene im Maushirn und 180 
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rhythmische synaptische Transkripte. Interessanterweise zeigen die beiden 
Gruppen nur eine geringe Überlappung, was darauf hinweist, dass die 
Rhythmik an der Synapse vor allem unabhängig von der Expression der 
Transkripte im Zellkern angetrieben ist. 
 
Synaptische mRNA-Transkripte werden durch RNA-Granulate entlang der 
Mikrotubuli transportiert und zwei Komponenten der RNA-Transport 
Maschinerie sind NONO und SFPQ welches Mitglieder des DBHS Familie von 
RNA-bindenden Proteinen darstellen. Interessanter Weise wurden diese 
Proteine ebenfalls mit dem zirkadianen System in Verbindung gebracht. 
 
Während die Rolle NONO und anderen DBHS Proteinen in Transkription und 
der zirkadianen Uhr bekannt ist, ist seine Funktion in synaptischer 
Morphologie und Funktion bis jetzt unklar. In dieser Arbeit haben wir gezeigt, 
dass sowohl NONO und PSPC1 die Struktur von inhibierenden Synapsen 
sowohl in-vitro als auch in-vivo in einem Maus-Modell in welchem das 
entsprechende Protein fehlt signifikant beeinflusst. Interessanterweise zeigen 
NONO und PSPC1 defiziente Mäuse gegensätzliche Gephyrin und GABAA-
Rezeptor α2 Morphologie sowie GABRA2 mRNA Spiegel. Darüber hinaus 
habe ich gezeigt, dass die Zerstörung von „Paraspeckles“ durch reduzierung 
des langen-nichtkodierenden nuklearen RNA Neat1 sich die Anzahl Gephyrin 
und GABAA Rezeptor α2 Clustern im Hippocampus der Maus signifikant 
erhöht. Angesichts der morphologischen Veränderungen in NONO defizienten 
Mäusen, welche im zweiten Teil der Arbeit beschrieben wurden, habe ich die 
funktionellen Eigenschaften von NONO näher studiert. Ich habe gezeigt, dass 
NONO defiziente Mäuse sowohl Verhaltens- als auch und kraniofaziale 
Anomalien, sowie globale transkriptionelle Dysregulation in Fibroblasten und 
Hippocampus-Gewebe zeigen. Diese Ergebnisse werden stark von der 
Erkenntnis dass Mutationen im NONO Gen beim Menschen eine neue 
Ursache für X-chromosomale syndromale geistige Behinderung, welche durch 
abnormale Gesichtszüge gekennzeichnet ist, unterstützt. Diese Erkenntnisse 
verknüpfen NONO mit dem Lernprozess und Gedächtnis und zeigen die 
Schlüsselrolle der DBHS Proteine in der funktionalen Organisation der 
GABAergen Synapsen. 
& & Introduction&
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1. General Introduction 
 
Thanks to its circadian clock, an organism is able to anticipate diurnal 
environmental changes in an adaptive fashion. Yet, these diurnal changes 
and the physiological responses to them also serve as timing cues to the 
clock, setting it to better match its environment. This chapter explores the 
molecular basis of this elegant interrelationship and its relevance for learning 
and memory. 
 
1.1 Circadian Clocks 
 
A circadian rhythm is an endogenously driven pattern of behavior or 
physiology in an organism that repeats periodically approximately each day. 
Such patterns exist in organisms throughout evolution, from bacteria to plants 
and animals (1). In metazoans, the prototypical example of a behavior that 
demonstrates a circadian rhythm is the sleep-wake cycle, with its alternating 
intervals of activity and with restfulness that recur with a periodicity 
approximating the 24-hour day-night cycle. Not only do circadian rhythms 
govern sleeping patterns, but in mammals they also play a part in controlling 
body temperature, hormone secretion, blood pressure, metabolism, and many 
other functions.  
 
1.2 Concept of Biological Clocks 
 
The mechanism underlying circadian rhythms is a biological “circadian clock.” 
Conceptually, circadian clocks can be divided into three quasi-independent 
processes: input pathways, which relay environmental information to a central 
pacemaker (clock); a circadian pacemaker, which generating the oscillation; 
and output pathways, through which the pacemaker regulates molecular and 
biochemical pathways that lead to rhythms in physiology and behavior. 
Circadian clocks, as opposed to other biological oscillators like the cell cycle 
or the menstrual cycle, meet four general criteria (2-4): i) their period length, 
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the time taken for one complete cycle, is about twenty-four hours (hence the 
word “circadian”, from the Latin circa diem, or “about a day”). ii) The rhythm 
must persist under constant environmental conditions, maintaining its 
periodicity of approximately 24 hours. iii) The rhythm exhibits temperature 
compensation, keeping roughly the same period length at different 
environmental temperatures. A normal biochemical reaction will approximately 
double its speed with every 10 degrees Celsius that the temperature 
increases, but circadian clocks do not. iii) The rhythm can be synchronized by 
environmental cues, commonly called zeitgebers (German for “timing cues”). 
This synchronization, or entrainment, allows the clock to change its phase, or 
internal time, to better match local external time.  
 
Thus, environmental zeitgebers induce molecular changes in the circadian 
oscillator that adjust it to the environment. One of the most potent of these 
cues is light, which is capable of changing clock phase in either direction 
depending upon the time that it is perceived, and thereby altering the timing of 
daily behaviors such as rest-activity cycles and feeding. Interestingly, 
however, both behavior (i.e. exercise) and feeding themselves can shift clock 
properties at a molecular level. The result is an oscillator that responds both 
to the exigencies of the environment and the reality of an organism’s behavior 
in it. In the following pages, we first outline the mammalian circadian oscillator 
at a molecular and systemic level, and then summarize current knowledge 
about its entrainment. 
 
1.3 Molecular Basis of Circadian Clocks 
 
Knowledge of the molecular components of the circadian clock was first 
established in the fruit fly Drosophila melanogaster, where mutation of the 
gene period (per) caused altered circadian rhythms (5). Subsequent isolation 
of the affected gene showed that that both per RNA and protein are 
expressed rhythmically! (6). Evidence that the PER protein product repressed 
transcription of its own gene led to the theory that regulation of the circadian 
rhythm on a molecular level is controlled by interlocking autoregulatory 
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feedback loops of transcription and translation that involve a set of clock 
genes and their protein products!(7). 
 
In mammals, the molecular set-up of the circadian clock may be schematically 
imagined as consisting of positive and negative elements! (7-9). Positive 
components include the two transcription factors CLOCK (circadian locomotor 
output cycle kaput) and BMAL1 (Brain and Muscle ARNT like 1) and their 
homologs. These transcription factors form heterodimers through their PAS 
and HLH regions and bind cis-acting E-Box sequences (consensus sequence: 
CACGTG) present in the promoter regions of many clock and clock-controlled 
genes. Among the genes so activated are the three period genes (mPer1–
mPer3 in the mouse) and two cryptochrome genes (mCry1 and mCry2), the 
key negative components of this feedback loop. 
 
 
Figure 1. Core clock components of the mammalian transcriptional - translational 
feedback loops. The positive elements of the primary feedback loop are represented by the 
CLOCK and BMAL1, which heterodimerize and initiate the transcription of target genes 
containing E-box cis regulatory enhancer sequences including Periods (Per1, Per2, Per3) and 
Cryptochromes (Cry1, Cry2). Negative feedback is achieved by PER: CRY heterodimers that 
translocate back into the nucleus and repress their own transcription. Casein Kinase 1 epsilon 
and delta are critical factors that regulate the core circadian turnover in mammals. The 
second regulatory loop induced by CLOCK- BMAL1 heterodimers activates the transcription 
of retinoic acid-related orphan nuclear receptors (Rev-erbα, Rorα) that consequently compete 
to bind retinoic acid-related orphan receptor response elements (ROREs) in the Bmal1 
promote. RORs activate transcription of Bmal1, whereas REV-ERBs repress the transcription 
process. (Fu & Lee; 2003) 
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To close this feedback loop, Per and Cry transcripts are translated in the 
cytoplasm several hours later and form multimeric complexes of unknown 
stoichiometry that are translocated back into the nucleus. There, they 
negatively regulate their own expression by repressing the transcriptional 
activity of CLOCK/BMAL1. A subsequent decline in PER and CRY protein 
levels through both lack of transcription and active post-translational 
modification, proteasome targeting, and degradation finally leads to a re-
activation of CLOCK/BMAL1 driven transcription and initiation of the next 
cycle. This basic feedback loop recurs autonomously on a daily basis.  
 
Other clock genes play a role in stabilizing the circadian rhythm by forming 
additional interlocked feedback loops. For example CLOCK/BMAL1 
heterodimers not only regulate transcription of Per and Cry loci, but also of 
retinoic acid-related orphan nuclear-receptor genes Rev-Erbα and RORα (10). 
The REV-ERBα protein represses Bmal1 transcription by binding to retinoic 
acid-related orphan receptor-response element (RORE) sequences in the 
Bmal1 promoter. Similarly, RORα also binds the RORE sequences in the 
Bmal1 promoter, but in contrast to REV-ERBα, RORα activates Bmal1 
transcription! (10, 11). Therefore transcription of Bmal1 is the result of 
competition between REV-ERBs and RORs at their specific response 
elements (RORE), interconnecting positive and negative feedback loops of 
the clock.  
 
In addition to transcriptional regulation, posttranslational mechanisms such as 
protein phosphorylation have been found to be critical in generating circadian 
oscillations! (12). For instance, casein kinase ε and δ(CK1ε/δ) are essential 
components of the feedback loops that generate circadian rhythm in 
mammals . CK1ε phosphorylates PER, CRY, and BMAL1 proteins! (12) . 
CK1δ, a close paralog of CK1ε, has also been found to be associated with 
PER/CRY complexes and may therefore perform a similar function. Although 
phosphorylation of clock proteins at different sites leads to varying effects, 
one key role of this modification is to favor ubiquitinylation and subsequent 
proteasome-mediated degradation of proteins thus modified. 
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1.4 Master and Peripheral Clocks 
 
From single-celled organisms to mammals, the basic circadian clockwork is 
cell-autonomous and present in most cells and tissues. Thus, individual cells 
(neurons, fibroblasts, hepatocytes, etc.) show circadian oscillations of gene 
expression, even in isolation. Nevertheless, in complex organisms like 
mammals, these clocks are arranged in a hierarchy (13). The master 
pacemaker of the mammalian circadian clock is located in the 
suprachiasmatic nucleus (SCN) of the anterior hypothalamus. The SCN is a 
heterogeneous tissue comprised of at least two broad regions. SCN neurons 
of the ventrolateral part (core) are heavily innervated by the 
retinohypothalamic tract and possess the unique property of inducing the 
expression of several genes, including Per1 and Per2, in response to light 
stimulation. However, their intrinsic circadian oscillations are weak. In 
contrast, cells of the dorsomedial part (shell) receive most of their information 
from the hypothalamus and limbic areas as well as from the core, and show 
strong autonomous rhythmicity but only weak activation by photic input. 
 
SCN-lesioned animals lose global circadian rhythmicity of diurnal behavior 
and physiology in constant conditions – e.g. corticosterone rhythm, drinking 
behavior and locomotor activity – and SCN grafts restore these rhythms. 
Thus, the SCN is responsible for entraining and synchronizing cellular clocks 
throughout the brain and body.  
 
1.5 Clock Genes In The Hippocampus 
 
The SCN is considered as master clock, coordinating circadian input such as 
light via different projections. A recent publication has identified around 35 
brain projections to the SCN and not less than 15 efferent signaling pathways 
(14). As previously mentioned, light is the main Zeitgeber for the SCN, 
Exposure to light leads to depolarization of RGCs, which innervate the SCN 
via the retinohypothalamic tract (RHT). The monosynaptic RHT fibers end 
directly on SCN neurons in the ventrolateral part of the nucleus. This 
information is further processed and projected to the dorsal medial 
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hypothalamus (DMH) through the subparaventricular zone. (sPVz), which in 
turn forwards in formation to other hypothalamic structures, which contain 
which projects to various regions in the hypothalamus, including the 
ventrolateral preoptic area (VLPO), the lateral hypothalamus (LH) and the 
paraventricular nucleus (PVN) (15, 16). The role hypothalamic structures 
include various biological processes such as thermoregulation, food 
anticipation, sleep-wake arousal and hormone secretion via the hypothalamo-
pituitary-adrenal (HPA) axis and the hypothalamo-pituitary-gonadal (HPG) 
axis, which will be discussed later. Evidence for the functional connection 
between the SCN and the hippocampus, a key region in memory formation 
and learning are however poorly understood. Indirect connections via the 
dorsal medial hypothalamus target to the locus coeruleus, which is a region 
activating cortical and hippocampal structures. 
 
Although the SCN serves as a master clock, several studies have shown that 
clock driven rhythms can be found in various tissues including the brain. For 
example, circadian rhythms of clock genes have been shown for brain 
structures such as the prefrontal cortex (17), olfactory bulb (18) and the 
hippocampus (17, 19), brain structure crucial for neuronal plasticity and 
memory processing. Using detailed biochemical gene expression studies 
combined with morphological immunohistochemical analyses, the authors 
demonstrate a robust circadian oscillation of core clock genes such as Per1, 
Cyr1/2, Clock and Bmal1, but not Per2 in the hippocampus of wildtype mice 
(19). Immunohistochemical colabeling studies revealed that clock gene 
protein expression was detected exclusively in in nuclei of cells of the Stratum 
pyramidale and the Stratum granulosum of hippocampal neurons, including 
parvalbumine positive interneurons, but not in astrocytes. Moreover, mice in 
which Per1 expression was disrupted showed significant disturbed expression 
profiles for core clock genes. 
& & Introduction&
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Figure 2. Anatomical circadian pathways in mice. In the mouse (Mus musculus), the 
suprachiasmatic nucleus (SCN) receives photic input through the retinohypothalamic tract 
(RHT). The SCN projects to the dorsal medial hypothalamus (DMH) through the 
subparaventricular zone (sPVz), which projects to various regions in the hypothalamus, 
including the ventrolateral preoptic area (VLPO), the lateral hypothalamus (LH) and the 
paraventricular nucleus (PVN). There are reciprocal connections between the VLPO and the 
tuberomammilary nucleus (TMN), which are thought to be partly responsible for the proper 
timing of sleep–wake rhythms. Functional connections between a circadian centre and a 
memory forming-centre, such as the hippocampus, are not well known. They may be partially 
gated through hypocretin- or orexin-expressing cells of the LH, or by melatonin secretion from 
the pineal gland following signaling from the PVN to the superior cervical ganglion (SCG). 
Note that C57BL/6J mice lack melatonin. OB, olfactory bulb. (Gerstner & Yin; 2010) 
 
In a large ex-vivo screen, neuronal tissue from rat containing Per1-luciferase 
transgene were used to monitor intrinsic Per1 expression in culture. Although 
many Per-expressing brain areas were arrhythmic in culture, 14 of the 27 
areas examined were rhythmic (17). Despite the high expression of Per1 in 
the hippocampus, the authors were not able to demonstrate intrinsic 
rhythmicity, whereas other tissues with comparable expression were able to 
recapitulate oscillations with a near 24h period for multiple cycles. Even 
though cell death could be excluded as a potential explanation for the lack of 
circadian oscillations, because forskolin evoked a healthy response, it is 
possible that the hippocampus failed to show circadian rhythmicity because 
culture conditions might have adversely affected those oscillations (e.g. by 
dispersion of interconnected neurons). A second explanation might be the fact 
that the SCN acts as the sole pacemaker that drives circadian rhythmicity in 
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the hippocampus. In line with this findings, Per2 oscillation in the amygdala 
and dentate gryrus of SCN lesioned Syrian hamster has been shown to be 
abolished, strengthening the slave oscillator hypothesis (20). Controversially, 
a similar study using luciferase labeled Per2 knockin mice, has demonstrated 
clear circadian rhythms of Per2-luciferase bioluminescence in the mouse 
hippocampus when monitored in the luminometer (21). This identified 
rhythmicity was claimed to be autonomous as they were present in isolated 
hippocampal slices which maintained in culture and thus independent of the 
SCN.  
 
1.6 Circadian Rhythms And Memory 
 
In the SCN of nocturnal rodent, neurons have been shown to exhibit diurnal 
changes in the spontaneous firing (SFR) and resting membrane potential 
(RMP) (22-27). This observation of course raises the possibility, that the SCN 
might drive time-dependent physiological and neuronal events downstream of 
the central pacemaker, including processes such as learning and memory.  
 
Despite the controversy of precise clock gene expression and regulation in 
the hippocampus, most of the studies argue for a strong role of circadian 
rhythms in learning and memory. In the hippocampus, two opposing 
mechanisms called long-term potentiation (LTP) and long-term depression 
(LTD) are widely believed to be the molecular basis of learning and memory 
(28). Based on their recent activity, a synapse can modify its efficiency to 
either fire more strongly by LTP, or less strongly via LTD. Although the 
molecular mechanisms underlying LTP and LTD is still under investigation, 
this sort of plasticity has been shown to change depending on the time of day 
in various nocturnal rodents (29-33). In a pioneer study, it has been shown 
that excitability of the rat denatate gyrus, a substructure of the hippocampus, 
indeed exhibits a circadian component (29). Interestingly, the peak of LTP in 
the dentate gyrus was found during the dark phase, while in contrast LTP in 
the CA1 area of the hippocampus was during the light phase. Involvement of 
circadian rhythms in LTP formation in the hippocampus was also proved in a 
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study performed in Syrian hamster (34) and mice (33). Although excitability of 
the CA1 region in Syrian hamster peaked in the light phase as described for 
rats, in contrast to the previous studies the tissue was harvested the opposite 
time of the day. This means, that LTP in the Syrian hamster was higher in the 
CA1 area from tissue, which has been harvested during the light period and 
then tested in the dark period. A further study performed in mice, has 
investigated the role of tissue harvesting and examination in respect to LTP in 
the CA1 region of the hippocampus (33). Hippocampal tissues harvested from 
mice during the light period, LTP was greater when examined in the dark 
period than during the light period, which is in contrast to the previously 
reported rat study. Finally, a study by Nakatsuka and coworkers performed in 
rats tried to answer this discrepancy, by applying theata-burst stimulation 
(TBS) instead of high-frequency stimulation (HFS) of the Schaffer collateral of 
the hippocampus (35). Recordings of population spikes (PS)-LTP during the 
light and the dark phase has revealed, that the magnitude of the LTP was 
larger during the dark phase compared to the light phase. Taken together, this 
studies implicate, that the time of testing is more crucial then time of 
harvesting and indicates that these circadian variations are rather 
autonomous and therefore independent of the central pacemaker. This idea fit 
with the previously observation, that isolated hippocampal slices maintained 
Per2 rhythmicity independent of the SCN. Additionally the circadian 
magnitude of LTP in the hippocampus is synchronized with the locomotor 
activity of these nocturnal rodents.  
 
To better understand the physiological consequences of clock genes upon 
learning and memory, several mode organisms ranging from fruit flies to mice 
deficient of core clock genes have been examined for memory defects. Mice 
lacking the core clock genes Cry1 and Cry2 (Cry double knockout mice) 
learned to avoid unpleasant sensory experiences (mild foot shock) and could 
locate a food reward in a spatial learning task (place preference) (36). These 
mice failed, however, to learn time-place associations. (36). However, the 
situation for the Period-gene is still a matter of debate: In a study, using 
Per1/Per2 double mutant mice, which exhibit an arrhythmic locomotor 
phenotype, no significant difference in terms of time-place learning compared 
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to wild-type mice was shown (37). Additionally, no deficiencies in short-term 
spatial working memory in Per mutant mice could been demonstrated. 
Moreover, both Per mutant and wild-type mice showed similar long-term 
memory for contextual features of a paradigm (a mild foot shock), measured 
in trained mice after a 2-month nontesting interval. (37). In line with this 
findings, examination of Per1/Per2 double mutant mice using two different 
learning and memory paradigms, a water-maze place navigation task and 
contextual fear conditioning, showed that none of these learning types were 
affected by the mutations, which suggests that Per does not play a major role 
in the regulation of hippocampus-dependent learning and memory (38). In 
contrast to these findings, Per1 deficient mice were accompanied by the loss 
of daytime-dependent differences in spatial working memory performance 
(39), which was related to the loss of circadian phosphorylation of cAMP 
response element-binding protein (CREB), a cellular transcription factor, in 
the hippocampus. Finally, the authors have been able to demonstrate 
physiological perturbations of LTP, a cellular correlate for long-term memory, 
upon Per1 depletion (39). In addition, a similar study on Per1 knockout 
animals has demonstrated a severe perturbation in a hippocampus-
dependent long-term spatial learning paradigm (19), supporting the idea that 
Per1 is indeed involved in the circadian learning behavior. Finally, Per2 
mutant mice exhibit deficits in the recall of trace, but not cued, fear 
conditioning (21).  
 
Circadian dependency on cognitive performance and memory formation have 
been shown in several behavioral paradigms (40-42). Surprisingly, circadian 
rhythms of locomotor activity are not an accurate predictor of the timing of 
optimal performance in memory tasks over the course of the day. For 
example, while the peak of memory performance of diurnal organisms such 
as zebrafish (D. rerio) (43) or the sea slug (A. californica) (44, 45) is shown 
during their active phase, fruitflys (D. melanogaster) and nocturnal rodents 
such as mice show highest cognitive performance during their inactive phase. 
(45, 46). These findings indicate, that locomotor activity is not the cause of 
circadian memory formation, because there is clear separation between 
resting state and memory performance in the different studied model 
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organisms. These results raise the question of the driving mechanism, which 
govern circadian memory and learning behavior. Beside the cellular and 
molecular core clock mechanisms, other factors such as neurotransmitter 
release, which regulates synaptic excitability and activity or hormones could 
potentially contribute to the circadian memory enhancement. 
 
One hormone, which is associated with circadian rhythms is melatonin. 
Melatonin is secreted by the pineal gland and it is under the circadian control 
of the SCN (47). The temporal release of melatonin is regulated in a circadian 
fashion in a wide range of organisms such as humans (48), zebrafish (49), 
sea slugs (50), mice (51), fruit flies (52) and low melatonin levels have been 
reported in autism spectrum disorders in the human (53-55). A study 
performed in zebrafish has shown, a clear time-of-day effect in acquisition 
(learning) and memory formation (43). This learning paradigm was then 
negatively correlated with high levels of melatonin: High melatonin levels 
during the night were resulted in lower periods of performance. Pinealectomy 
or treatment with a melatonin receptor antagonist ultimately rescued reduced 
cognitive performance during the dark phase, supporting the idea that 
melatonin is supporting memory and learning behavior (43). Studies 
performed in C57Bl/6J mice, which lack melatonin and C3H mice, which 
express melatonin has shown, that mice deficient of melatonin show less 
time-of-day-dependent changes in hippocampal LTP than mice secreting 
melatonin (33). However, circadian learning performance cannot be attributed 
completely to melatonin because mice deficient for melatonin still show time-
of-day-dependent changes in memory formation (46) and therefore additional 
factor must contribute to diurnal memory performance. 
 
A second class of hormones are glucocorticoids, which are produced by the 
adrenal gland, regulate a variety of physiological processes such as 
metabolism, immune response, cardiovascular activity, and brain function and 
his highly associated with stress response (56). Glucocorticoids can bind the 
glucocorticoid receptor (GR) a nuclear hormone receptor found in many cell 
types but not in the SCN (57) and it has been shown to exhibit both ultradian 
and circadian rhythmicity (52, 57, 58). Disruptions of the SCN by targeted 
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lesions have shown that circadian aspects of the rhythmic release of 
glucocorticoids indeed underlie the central pacemaker (59-61). Many studies 
have shown, that excessive glucocorticoid secretion upon chronic stress 
affect learning and memory in a negative fashion (62-64) and that they are 
able to regulate spine development and plasticity in-vivo (65). A recent study 
by the laboratory of Liston and coworkers has shown that thin spine 
development and plasticity is tightly tied to the circadian rhythmicity of 
corticosteroid secretion and are differentially regulated by glucocorticoid and 
mineralocorticoid receptor-dependent mechanisms (66). Taken together, 
these results show that circadian oscillations of glucocorticoids are important 
for learning-dependent synaptic formation and maintenance. 
 
As mentioned previously, in addition to hormones neurotransmitter could 
potentially modulated circadian learning and memory behavior. One of the 
major inhibitory neurotransmitter in the central nervous system (CNS) of 
mammals is gamma-aminobutyric acid (GABA). The study by Ruby and 
coworkers elegantly connects the role of circadian learning performance via 
the neurotransmitter GABA. Instead of disrupting the circadian rhythm by SCN 
lesions, Siberian hamsters (Phodopus sungorus) have been made arrhythmic 
by a single 2h exposure to light during the night which was followed by a 3h 
phase delay the next day (67). Control hamster showed circadian 
performance in the novel object recognition (NOR) task, a memory test which 
is under the control of the hippocampus. By contrast, hamsters, which have 
been made arrhythmic, did not exhibit circadian learning pattern and in 
addition performed significantly worse compared to control wildtype 
littermates. Furthermore, the authors have shown that disturbed sleep 
patterns during the experiment in these animals could be excluded as 
cofounding factor since sleep deprivation did not restore learning impairment 
in arrhythmic hamsters. Surprisingly the GABA antagonist pentylenetetrazol 
completely restored the circadian sensitivity of learning the task indicating an 
important role of GABA in the circadian memory processing. A functional role 
for GABA in circadian LTP has been recently shown by the laboratory of 
Natsume and coworkers where local application of Gabazine, a GABAA 
receptor antagonist, mimicked nighttime disinhibition and thereby facilitated 
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LTP in the CA1 region of the rat hippocampus (Nakatsuka and Natsume, 
2014). 
 
1.6 Organization Of The Inhibotory GABAergic Synapse 
 
Beside glycine, gamma-aminobutyric acid (GABA) is one the most important 
inhibitory neurotransmitter in the central nervous system (CNS) of mammals. 
While glycine primarily mediates fast inhibition in the brain stem and spinal 
cord, GABA acts mainly in the central brain. GABA is synthesized in 
presynaptic terminals of interneurons by the enzyme glutamic acid 
decarboxylase (GAD) and the vesicular GABA transporter (vGAT) enzyme 
enriches the neurotransmitter in presynaptic vesicles (68). Interestingly, both 
GAD activity and GABA levels have been shown to exhibit circadian 
oscillations in the rat SCN and regulates neuronal coupling (69). Upon arrival 
of an action potential at the presynaptic site, Ca2+ channels in the plasma 
membrane open, leading to depolarization by Ca2+ influx. This depolarization 
triggers the exocytosis of some of the presynaptic vesicles containing GABA 
into the synaptic cleft. 
 
Upon binding of GABA, GABAA receptor (GABAAR), a ionotropic chloride 
channel, mediate fast synaptic inhibition by activation whereas GABAB 
receptors (GABABR), a G-protein coupled receptor, mediate slow and 
prolonged neuronal inhibition by indirectly affecting downstream effector 
pathways via Gi/o associated proteins. GABAA receptors belong to the Cys 
loop superfamily of ligand-gated ion channels, which are encoded by a family 
of 19 subunits (α1-α6, β1-β3, γ1-γ3, δ, ε, π, θ, and ρ1-ρ3) and exhibit four 
transmembrane domains per subunit (68). The functional GABAA receptor 
complex has a pentameric structure existing in a variety of possible 
combinations of protein subunits. 
 
Through the proximity of the receptor to the transmitter release site within the 
synapse, the kinetics of the IPSP is tightly controlled. Phasic inhibition plays a 
key role in synchronizing neuronal activity. Tonic inhibition, on the other hand, 
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is mediated by extrasynaptic receptors generating low amplitude currents 
evoked by ambient GABA spilling over from the synaptic cleft. Extrasynaptic 
GABAAR are involved in the regulation of neuronal excitability and plasticity 
(72). Synaptic GABA receptor exhibit a lower affinity for GABA than the 
extrasynaptic receptors  
 
In the brain, most GABAA receptors are composed of two α, two β and one 
γ/δ/ε subunit. Differential composition of the pentameric receptor by subunit 
combinations defines specific localization, kinetics properties and 
pharmacological profile. For instance, receptors mediating fast inhibition 
contain mainly α, β and the γ2 subunit and are located adjacent to the 
presynaptic inhibitory bouton while receptors containing the δ or ε subunit in 
place of the γ subunit, are benzodiazepine insensitive and are exclusively 
located at extrasynaptic sites and typically they exhibit a higher affinity for 
GABA than synaptic receptors (70, 71). Synaptic GABA receptors regulate a 
process called inhibitory postsynaptic potential (IPSP), which is a fast, high 
amplitude phasic current, generated by the release of presynaptic GABA and 
fast clearance from the synaptic cleft be neurotransmitter reuptake through 
dedicated transporters. This inhibition is believed to play a major role in 
synchronizing neuronal activity. In contrast to synaptic receptor, extrasynaptic 
receptors are involved tonic inhibition generating relatively low amplitudes and 
prolonged receptor activation mainly by a spillover of synaptic GABA. Tonic 
inhibition is involved in the regulation of neuronal excitability and plasticity 
(72). 
 
Various brain regions perform different tasks and therefore require different 
molecular specialization, which translates to distinct signaling profiles. 
Therefore, it is not surprising, that specific GABAR subunits are localized in a 
specific manner in the brain to satisfy this needs. The expression of seven 
major GABAAR subunits has been studied in detail by immunohistochemistry 
in the adult rat brain (73). For example, the α1 subunit which shows the 
fastest decay kinetics among the α subunits has been shown to be highly 
expressed throughout the brain, while other subunits exhibit more specific 
sublocalization (74). In the adult brain, the α2 subunit is highly expressed in 
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the hippocampus and shows a distribution pattern, which is opposite to the α1 
subunit, being highly, expressed where α1 subunit expression is low relatively 
low. The α3 subunit distribution is similar to that of α2, although expression 
levels are reduced. The α5 subunit has been shown to be expressed in the 
olfactory bulb, hippocampus and spinal trigeminal nucleus. The γ2 subunit, 
which is essential for postsynaptic localization of GABA receptors, is 
ubiquitously expressed, while in contrast γ1 subunit expression is mainly 
restricted to the hypothalamus, amygdala, parts of the basal ganglia and the 
inferior olivary nucleus. The subunits β2 and β3 subunit has been shown to 
co-localize with α1 or α2 subunits in the adult brain, although β1 expression is 
relatively low compared to β1. Finally, extrasynaptic GABAA receptors 
typically are characterize by the assembly of two α4, α5 or α6 subunits, 
together with two β and the δ or γ2 subunit (75). The δ subunit is expressed in 
the forebrain together with the α4 subunit or the α6 subunit in the cerebellum. 
(73) 
 
Functional studies of the relevance of GABAAR subunit composition was 
studied by targeted gene deletion. Depletion of the GABRA1 gene, which 
codes for the α1 subunit, showed strong compensation by increased 
expression of α2 and α3 in the thalamus and cerebellum but ultimately did not 
result in any major behavioral changes! (76). Disruption of the α2 subunit in 
mice resulted in receptor rearrangements in CA1 pyramidal cells, but no 
replacement by the α1 subunit was observed. Interestingly, 
electrophysiological recordings in CA1 pyramidal cells from α2-KO mice 
showed a significant decrease in GABAergic mIPSC frequency, with 
unchanged amplitude and kinetics! (77). Among all the GABA receptor 
subunits, the γ2 subunit is probably the most crucial for proper receptor 
function and development, since it’s disruption causes postnatal lethality (78). 
 
The majority of excitatory (symmetric) synapses in the mammalian brain are 
found on protrusions of the neuron, also referred as spines, whereas most 
inhibitory (asymmetric) synapses are formed on the dendritic shaft, as well as 
on the soma and axonal initial segment!(79). Therefore, specific mechanisms 
must exist in order guarantee the correct localization of the postsynaptic 
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receptors with the presynaptic terminal.  
 
The inhibitory postsynaptic density (PSD) is an asymmetric, electron dense 
structure adjacent to the presynaptic active zone and contains a high 
concentration of ligand-gated ion channels. In addition, further proteins allow 
the bridging between pre- and postsynaptic site and the proper scaffolding of 
inhibitory receptors to the postsynaptic membrane, preventing the lateral 
diffusion out of the synaptic cleft. Different effector proteins, kinases, and 
phosphatases are concentrated at the PSD and facilitate fast signal 
transduction.  
 
Figure 3. The GABAergic synapse. 
Synaptic GABAA receptors are 
stabilized by a submembranous lattice 
of gephyrin by direct interaction. 
Cytoskeleton associated proteins are 
Dlc1/2 and Mena/VASP. Collybistin, a 
guanine nucleotide exchange factor is 
membrane associated and interacts 
with gephyrin. The dystrophin-
glycoprotein complex (DGC) stabilises 
the synapse and neuroligins bridge the 
synaptic cleft by interaction with 
presynaptic neurexins. Adapted from 
Tretter & Moss (2008). 
 
 
 
 
 
One protein that has been strongly associated with the regulation and 
anchoring of GABAARs at inhibitory synapses is the multifunctional 93 kDA 
protein gephyrin, which self-assembles into a scaffold and interacts with the 
cytoskeleton. Initially, gephyrin was identified which by the interaction with 
glycine receptors, where directly binds to the intracellular domain of the β 
subunit of glycine receptors, stabilizing them at inhibitory synapses in the 
spinal cord (75). Gephyrin is a highly conserved multifunctional protein and 
despite the initial identification in the CNS gephyrin is also widely expressed 
in non-neuronal tissues required for the catalysis molybdenum cofactor 
(MoCo) biosynthesis (80). Subsequent studies have demonstrated that 
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GABAA receptors are anchored postsynaptically by gephyrin and binding to 
GABAA receptors is mediated by interaction sites that have been mapped 
within the intracellular loop of GABAA receptors α1, α2 and α3 subunits (81, 
82), even though with lower binding affinity compared to the β subunit of 
glycine receptor! (83). However, in contrast to glycine receptors, targeted 
depletion of α subunits has revealed, that not all receptor subtypes are 
clustered by gephyrin dependent mechanisms!(84). 
 
In vertebrates, the structure of gephyrin is highly conserved and consists of 
three domains, namely G, C and E domains! (74). The flanking G and E 
domain are homologous the bacterial MogA and MoeA proteins, responsible 
for the MoCo synthesis and are linked by an unstructured C-domain. The 
flexible C-domain of gephyrin contains multiple sites for protein interaction 
and for post-translational modification and with proteins that regulate synapse 
formation and function. Due to the relatively high instability of the C-linker 
domain, the full-length structure of gephyrin by crystallography remains an 
unsolved task until today. Biochemical and structural analysis of isolated 
subdomains of gephyrin have shown a trimerization for the G domain as well 
as dimerization for the E domain! (85). Taking this information into account, a 
hexagonal lattice structure was proposed for gephyrin at the postsynaptic site, 
forming a two-dimensional scaffold (86). 
 
Depletion of gephyrin in mice neurons by targeted deletion or by gene 
silencing has shown, that absence of gephyrin significantly reduced 
postsynaptic clusters containing α2 and α3 GABAAR subunits! (78, 87). 
Nevertheless, α1 subunit expression and localization was not impaired, thus 
indicating a clustering mechanism, which is gephyrin independent (84). 
Interestingly, gephyrin depends on the presence of GABAAR to form 
postsynaptic clusters in GABAergic synapses, and the size and density of 
gephyrin scaffolding can be correlated to strength and frequency of 
GABAergic transmission. Thus, gephyrin clustering is largely impaired in the 
mice lacking the GABAAR α2 subunit. Similarly in GABAAR α1 knockout mice 
gephyrin clustering at postsynaptic sites is impaired, leading to intracellular 
aggregates. This results show, that both gephyrin and GABAAR clustering 
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reciprocally regulate their clustering at the inhibitory postsynaptic site. In 
addition to GABAAR, gephyrin interacts with several other proteins at the 
PSD, including cytoskeletal, signaling, and trans-membrane proteins 
 
As previously mentioned, the C-linker domain of gephyrin has been shown as 
a target for protein-protein interactions and posttranslational modifications and 
potentially modulate the clustering of GABAA receptors the synapse. Over the 
last decades, several phosphorylation residues on gephyrin have been 
identified. For instance, our laboratory has identified two relevant 
phosphorylation sites: Ser268 is phosphorylated by extracellular signal-
regulated kinases 1 and 2 (ERK1/2) and overexpression of phosphor-deficient 
mutant in cultured neurons significantly increased gephyrin cluster size (88). 
These morphological changes are accompanied by changes of amplitude and 
frequency in miniature GABAergic postsynaptic currents. On the other hand, 
Ser270 is phosphorylated by glycogen synthase kinase 3β and 
overexpression of the phoso-deficient mimicking gephyrin construct in primary 
hippocampal neurons demonstrated a reduction in gephyrin cluster density 
(89). Thereby, the phosphorylation status of this identified residues can 
regulate the number and size of synaptic gephyrin and fine-tune synaptic 
plasticity. Beside phosphorylation, gehyrin has also been show to be target of 
further post-translational modifications such as palmitoylation or SUMOylation 
(88-90). 
 
1.7 NONO – A Link between Circadian Rhythms And Memory? 
 
Initially, our lab has identified the RNA binding protein NONO as a Per1 
associated component (91). Disruption of NonA (the Drosophila homolog of 
NONO) function has shown that fruit flies harboring a hypomorphic allele 
show hyperactive behavior and mild arrhythmicity. Additionally, NonA deficient 
flies exhibit significantly decreased mRNA expression of the clock gene 
timeless as well as dampened rhythmicity. Interestingly, although NONO 
protein expression is constant, binding to the clock gene Per1 has been 
demonstrated to occur in a circadian fashion. In a subsequent study, mice 
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which have been depleted for NONO have shown show only small changes in 
period length or clock gene expression (92) and thus the authors speculated 
that in mammals the lack of NONO may be compensated by other protein 
family members. NONO belongs to the highly conserved Drosophila Behavior 
Human Splicing (DBHS) protein family and this family includes three members 
in mammals, namely NONO, Paraspeckle Component 1 (PSPC1), and 
Splicing Factor Proline/Glutamine-Rich (SFPQ, also known as PSF). The 
speculations of the authors regarding compensation of NONO by other family 
members have been confirmed recently at least on the protein level since 
murine embryonic fibroblasts (MEFs) from mice lacking NONO exhibit 
significantly increased PSPC1 levels (93).  
 
NONO, a Non-POU-domain-containing, Octamer-binding protein, was 
originally identified in mouse by Yang and coworkers in 1993 as the 
mammalian homolog of Drosophila NonA gene! (94). Subsequently, the 
human homolog was found in HeLa cells where it was named p54/nrb for 
Nuclear RNA-Binding protein, 54 kDa and was included in the novel 
Drosophila Behavior, Human Splicing (DBHS) protein family together with the 
human Factor Proline/Glutamine-rich PSF/SFPQ and the Drosophila 
NONA/BJ6V as they all share the phylogenetically conserved protein segment 
of 320 amino acid, termed DBHS domain!(95). P54NRB and SFPQ also share 
regions rich in proline and glutamine residues outside the main homology 
region. These proteins can form homo- and heterodimers in vivo (96-99)!and 
are implicated in a wide variety of cellular processes, many of which are 
related to RNA. 
 
First, NONO/P54NRB and PSF/SFPQ together with paraspeckle protein 1 
PSPC1/PSP1, another DBHS protein family member, localize to paraspeckles 
(100-106). Paraspeckles are subnuclear bodies found in the interchromatin 
space of mammalian cell nuclei (100, 107). These ribonucleoprotein 
structures, built on the long non coding RNA (lncRNA) NEAT1 (also known as 
MENe/b) play a key role in the nuclear retention of adenosine-to-inosine 
hyperedited RNAs, and in storage and rapid release of certain RNAs under 
stress conditions (108-110). Second, NONO/P54NRB as well as PSF/SFPQ, 
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have also been shown to regulate DNA unwinding and pairing (111, 112), 
transcriptional activation and repression (113-122), pre-mRNA processing 
(123-125) and splicing (126-128). Third, P54NRB/NONO and PSF/SFPQ 
have been involved in DNA damage response (93, 129-133) and RNA 
transport in neurons (134). Other studies demonstrated that P54NRB/NONO 
and PSF/SFPQ are both phosphorylated during mitosis, altering their protein 
interactions or functional properties (112, 135, 136). Another study suggests 
that P54NRB/NONO could play a role in the maintenance of pH homeostasis 
in the nucleus through its Carbonic Anhydrase activity (137). Lastly, 
NONO/P54NRB and other DBHS family members serve as transcriptional 
cofactors necessary for correct circadian clock function in both flies and 
mammals (91, 92, 138), and through interaction with PER proteins can confer 
circadian clock regulation upon various downstream processes such as 
wound healing (139). 
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2. Aims of the Thesis 
 
Sub-cellular localization of mRNA plays an essential role in cell function, 
especially during development and in neuronal plasticity. However, despite 
the recent progress in the identification of synaptic transcripts and RNA 
transport mechanism, little is know about the circadian regulation of mRNA 
transcripts at the synapse.  
 
Therefore, in the first part of the thesis I wanted to address the question, 
weather there are synaptic enriched genes, which are regulated in a circadian 
fashion at the synapse. As a first step, the isolation of synaptic transcripts had 
to be established in order to identify synaptic enriched genes. After successful 
implementation of synapse purification, transcriptomic analysis of circadian 
synaptosomes has been performed to identify rhythmic transcript at the 
synapse. Finally, bioinformatical analysis has revealed that a specific subset 
of synaptically enriched transcripts indeed exhibits rhythmic behavior and in 
addition is independent of the circadian core clock. 
 
The role of RNA binding proteins in synaptic morphology and plasticity is only 
poorly understood. Two components of RNA transport granules which also 
have been linked to the circadian system are NONO and SFPQ, members of 
the DBHS family of RNA-binding proteins. While the role of NONO and other 
DBHS proteins in transcription and circadian clock regulation is known, its 
function in synapse morphology and function is up to now unclear. Because of 
the involvement of the DBHS family of proteins in RNA transport in neurons 
and because they formed specific RNA holding structures in the nucleus, we 
guessed that these proteins might play a role in postsynaptic structure, 
perhaps through regulated RNA transport. The aim of the project is to 
characterize the function of DBHS proteins and paraspeckles in regulating 
synaptic morphology. As a first step to elucidate the role of these proteins in 
regulation of synaptic signaling, the influence on they assembly and stability 
of the inhibitory postsynaptic density was investigated in-vitro as well as in-
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vivo with the main focus on gephyrin, which is a major scaffolding protein at 
inhibitory synapses in the CNS.  
 
Finally, I wanted to understand some of the functional consequences of this 
regulation. It is presumed that changes in inhibitory synapse morphology, 
which is reported in the second chapter, are correlated with changes in the 
localization and function of neurotransmitter receptors. Therefore I have 
investigated the direct consequence of such changes in more detail for NONO 
deficient mice where I show, that NONO knockout mice have intellectual and 
anxiety-related deficits. We trace these effects to specific defects at inhibitory 
synapses, where NONO regulates both synaptic transcription and gephyrin 
scaffold structure. Our data identify NONO as a new neurodevelopmental 
disease gene and highlight the key role of the DBHS protein family in 
functional organization of GABAergic synapses 
 
 
 
 
& & Results&
! 23&
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Abstract 
 
Intrinsic circadian clocks allow organisms throughout the animal kingdom to 
synchronize their biology and behavior to the 24h light-dark changes and in humans, 
several observations link cognitive disorders to circadian rhythm anomalies. The 
molecular basis of memory and learning in the brain is thought to be a consequence 
of the phenomenon called as Long Term Potentiation (LTP) and Long Term 
Depression (LTD), causing constant remodeling of the synapse. This modification of 
the synapse induces short- and long lasting morphological and functional alterations 
at the synaptic entity and it has become clear, that these forms of synaptic plasticity 
require local protein synthesis. Recent findings have shown that, in dendritic 
processes, protein synthesis is operated on a small and localized scale directly next 
to the remodeling synapses. Over the last decades new techniques have greatly 
helped to better understand the process of local mRNA trafficking and the 
identification of synaptic transcripts in high spatial resolution. However, despite the 
recent progress in the identification of synaptic transcripts and RNA transport 
mechanism, little is know about the circadian regulation of mRNA transcripts at the 
synapse. Here, we describe the identification of circadian synaptic transcripts in the 
mouse brain. Next-generation sequencing has revealed totally 900 rhythmically 
expressed genes in the mouse brain and 180 rhythmic synaptic transcripts. 
Interestingly, both populations exhibit only a poor overlap, indicating that rhythmicity 
at the synapse is mainly driven independent of the nuclear transcriptional forward-
feedback loop. 
Introduction 
 
A circadian rhythm is an endogenously driven pattern of behavior or physiology in an 
organism that repeats periodically approximately each day. Such patterns exist in 
organisms throughout evolution, from bacteria to plants and animals. In metazoans, 
the prototypical example of a behavior that demonstrates a circadian rhythm is the 
sleep-wake cycle, with its alternating intervals of activity and with restfulness that 
recur with a periodicity approximating the 24-hour day-night cycle. Not only do 
circadian rhythms govern sleeping patterns, but in mammals they also play a part in 
controlling body temperature, hormone secretion, blood pressure, metabolism, and 
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many other functions (1). Additionally, in humans several observations have link 
cognitive disorders to circadian rhythm anomalies!(2-7).  
 
Activity dependent synaptic changes are required for memory formation and storage 
in the brain described by the models of long-term potentiation (LTP) and long-term 
depression (LTD). A considerable aspect of this synaptic plasticity is determined 
postsynaptically by regulating the localization and the density of neurotransmitter 
receptors. It has now become evident that protein translation is required for the late 
phase of LTP and intermediate stages of LTD are dependent on new protein 
translation being independent of transcription. This compartmentalization between 
mRNA synthesis and translation of proteins, which are present in a repressed phase 
allows fast rapid local response to a certain stimuli. Trafficking of specific mRNA 
does not take place unattended, but accompanied by a whole set of proteins 
consisting of RNA-binding proteins, targeting specific mRNAs to the synapse.  
 
Neurons, which are one of the main components in the brain of organisms exhibit a 
high degree of compartmentalization compared to other cell type, enabling fast signal 
processing. They are characterized by a soma, dendrites and synapses, and axonic 
processes which can be in the most extreme situations up to couple of meters long. 
Beside the rapid information propagation/transmission, this compartmentalization 
causes a significant biological hurdle in terms of protein transport. For example, 
synaptic molecules such as neurotransmitter receptors have to be first be 
synthesized in the soma, packaged in vesicles and transported along the dendrites 
using microtubules, sorted at branch point and finally integrated at site of interest. 
 
The study of synaptic transcripts in neurons has been cumbersome for a very long 
time, mainly due to technical hurdles. However, over the last decades techniques 
such as Next-Generation Sequencing (NGS) and high-resolution in-situ analysis 
have greatly helped to better understand the process of local mRNA trafficking and 
the identification of synaptic transcripts. In a recent study, Schuman and coworkers 
have identified the transcriptome of the neuropil in the rat hippocampus combining 
microdissection (8), NGS and high-resolution in situ hybridization, yielding 2550 local 
transcripts. Within these genes, mRNA transcripts for proteins with known roles in 
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LTP/LTD such as calmodulin-dependent kinase IIα (CaMKIIα) or GABA receptors, 
have been identified, supporting the local protein synthesis model.  
 
A circadian rhythm is an endogenously driven pattern of behavior or physiology in an 
organism that repeats periodically approximately each day and an increasing number 
of studies have demonstrated that alteration in the circadian system affect learning 
and memory. In Drosophila, the circadian clock controls daily changes in neuronal 
and synaptic structure (9-12). In zebrafish, induction and/or formation of long-term 
memory is modulated by a circadian clock and both learning and memory formation 
occur better during the day than during the night (13). In mice, circadian fluctuations 
are important for learning and memory by promoting learning-associated spine 
formation and elimination (14).  
 
However, despite the recent progress in the identification of synaptic transcripts and 
RNA transport mechanism, little is know about the circadian regulation of mRNA 
transcripts at the synapse. Here, we describe the identification of circadian synaptic 
transcripts in the mouse brain using Next-generation sequencing. 
 
Results 
 
In a recent study it has been shown, that transmembrane proteins in synaptosomal 
preparation from rodent brain and in undisturbed synapses from brain slices highly 
correlate (2). To investigate the synaptic transcriptome, we established a protocol to 
isolate mRNA from synaptosomes. The successful isolation of synaptosomal mRNA 
from mouse brain was investigated biochemically by deep-sequencing showing 
enrichment for know genes such as CaMKIIα, GABRA2, Arc or Homer2 in 
synaptosomal compartment compared to total homogenate (see Study III). As 
expected, these results have been confirmed by qPCR analysis for GABRA2 and 
CamK2a mRNA, which showed 2-3 fold enrichment in synaptosomes compared to 
brain homogenate (see Study III). Additionally Neat1, a nuclear long-noncoding RNA 
was significantly reduced in the synaptosomal fraction, indicating a high quality 
purification procedure (see Study III). 
As a next step, we have harvested mouse brain from animals under constant 
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darkness in a circadian fashion and subjected them to synaptosomal preparation. 
Total brain homogenate and synaptosomes were used to isolate mRNA and 
submitted to High-Throughput Sequencing and circadian expression of known core 
clock genes such as Per1, Per2, Clock and Bmal in total brain homogenate served 
as control for the successful circadian profile. Indeed, mRNA transcript levels of 
these genes were expressed in a rhythmic fashion, confirming circadian sampling 
and data processing (Figure 1A). To confirm successful isolation of synaptic 
components, transcript known to be enriched at synapse such as Kif5a and CaMKIIα 
were studied over the course of 24h showing constant high expression in 
synaptosomes (Figure 1B). Beta-Actin, which served as a marker for housekeeping 
gene, exhibits constant reduced expression levels in synaptosomes compared to 
total brain homogenate (Figure 1B). 
 
 
Figure 1. Circadian transcriptomic profile of clock genes and synaptic enriched genes 
around the clock. (A) Transcript level of circadian core clock genes Per1, Per2, Clock and 
Bmal at different circadian timepoints (CT) relative to CT0 in total mouse brain homogenate 
analyzed by High-Througput-Sequencing (HTS). (B) Enrichment of known synaptic localized 
transcript at CT0-CT20 in synpatosomes of the mouse brain compared to total homogenate. 
Actin is indicated as control. n = pool of 3 mice per time point. 
 
To identify potential circadian fluctuations of mRNA at the synapse, it is important to 
separate circadian transcription from circadian transport or degradation of mRNA at 
the synapse. Ideally, constant transcript levels in the homogenate and circadian 
expression at the synapse would be indicative of such a phenomenon. Therefore, in 
a first step we have identified all the expressed genes in the mouse brain, which 
consisted of totally 13’050 genes. Next, to investigate genes with rhythmic 
expression, transcripts, which exhibit a maximum to minimum ratio of 1.5 during the 
period of 24h, were further considered for circadian expression (2826 genes). As a 
last step, this 2826 genes were further analyzed by JTK_CYCLE, a nonparametric 
Results!
! 28!
test for circadian expression, identifying totally 900 rhythmically expressed genes, 
which is 6.9% of totally expressed genes (Figure 2).  
 
Secondly to identify rhythmic expressed synaptic transcripts, from the 13’050 
expressed genes, we categorized mRNAs as enriched when they had an 
synaptosome/homogenate ratio of ≥1.5 and potentially rhythmic when they exhibit a 
amplitude-ratio (peak/trough) ≥1.5. Combining both tests, we have categorized 1307 
genes, which were further submitted to analysis by JTK_CYCLE. From these genes, 
totally 180 have passed at least one of the statistical tests, representing synaptic 
enriched genes with circadian expression profile (Figure 2). 
 
 
 
Figure 2. Flowchart of the identification of circadian synaptic genes.  
 
Interestingly, the Venn diagram of those two categories shows only a poor overlap 
between circadian expressed genes in total brain tissue and synaptic enriched genes 
(Figure 2), indication that rhythmicity at the synapse is not driven by the main 
transcription translation feedback loop. 
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Visual selection of synaptic circadian expressed genes previously identified by the 
filtering method confirmed a circadian enrichment-profile, while transcript levels were 
constant in total homogenate. Among the identified genes, Tenascin C (Tnc), 
Glypican 2, cerebroglycan (GPC2), Adducin 3 (Add3) and Calcium-regulated heat 
stable protein 1 (Carhsp1) are potential candidates for the circadian transport of the 
mRNA (Figure 3).  
 
 
Figure 3. RNA-Seq expression plots for four examples of transcripts whose enrichment at 
the synapse is circadian while transcript levels are constant in total brain homogenate. Note 
that Glypica2 shows an inverted phase compared to Tenascin C, Adducin 3 or Calicium-
regulated heat stable protein 1. n = pool of 3 mice per time point. 
 
Discussion 
 
The molecular mechanisms behind synaptic plasticity have not been completely 
characterized, but it become evident, that local protein synthesis in dendrites plays 
an important role. This compartmentalization between mRNA synthesis and 
translation of proteins allows fast rapid local response to a certain stimuli. Trafficking 
of specific mRNA does not take place unattended, but accompanied by a whole set 
of proteins consisting of RNA-binding proteins, targeting specific mRNAs to the 
synapse. While it has become clear, that a specific set of mRNA localizes to in 
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dendrites and synapses by a very dedicated RNA transport machinery, yet very little 
is known about the temporal resolution.  
 
Here, we have identified transcripts, which in addition to their synaptic enrichment 
exhibit prominent circadian rhythmicity. Interestingly, among this identified 
transcripts, only 15.5% show rhythmicity in total brain extracts, indicating a 
mechanism, which mainly is driven independently by the circadian transcription of 
this transcripts. A plausible explanation for this phenomenon would be the circadian 
transport of mRNA from the soma along the microtubule to synapse. As a first step 
more research is needed to identity the proteins that bind these mRNA in the 
transport granule. Given the fact, that the identified transcripts show different 
circadian phase, probably different RNA transport granules might be involved at 
different circadian time points. Studies of RNA transport granule by Hirokawa and 
coworker have demonstrated a high complexity regarding protein composition (15). 
The analysis of RNA-transporting granules by gel electrophoresis and mass 
spectrometry revealed 42 proteins, some of them containing known RNA-binding 
properties like staufen, syncrip or DDX1/DDX3. Given the high complexity of these 
granules, the identification of mRNA composition remains still very challenging.  
 
An alternative circadian mechanism, by which mRNA is regulated at the synapse 
would be the regulation of transcript stability. In mammals, mRNA localization and 
stability is highly regulated by its 3’ untranslated region (UTR), especially by 
shortening of the poly(A) tail. For instance, poly adenyl binding protein (PABP) 
associates with the 3’ end of mRNA to regulate polyadenylation and preventing the 
transcript from being degraded and therefore any factors that affect the rate of 
deadenylation will alter the half-life of the mRNA. One recently identified circadian 
deadenylase and potential target is Nocturnin (16). While the role of Nocturnin (Noc) 
has been extensively studied in peripheral processes such as lipid metabolism, 
adipogenesis, glucose homeostasis, inflammation and osteogenesis, however it’s 
localization and role in the brain remains largely unknown. 
 
Finally, there is increasing evidence that dendritic mRNA may be translationally 
silenced by miRNA in response to synaptic activity! (17) and thereby promote the 
decay of their mRNA targets. A recent study by Gattfield and coworkers suggest, that 
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in hepatocytes miRNA targeted transcripts affect up to 30% of the rhythmic 
transcriptome!(18). Given the fact, that miRNA’s are highly expressed in the mammal 
brain, a similar mechanism might be involved in the regulation of rhythmic expression 
of synaptic transcripts. Besides of the molecular mechanism of circadian targeting of 
synaptic transcripts, the underlying physiological trigger remains largely elusive. 
 
Material and Methods 
 
Mice 
All experiments were performed by using C57Bl6 adult wild type mice. Animal 
housing and experimental procedures are in agreement with veterinary law of the 
canton of Zurich. For circadian experiments, mice have been housed in constant 
darkness. 
 
Synaptosome preparation  
Synaptosomes have been prepared as described previously45. In brief, mouse brains 
were homogenized in 5 ml homogenization buffer (0.32 M sucrose, 1 mM EDTA pH 
7.4, 1 mM dithiothreitol, phenylmethanesulfonyl fluoride solution (Sigma, 93482-
50ML-F), complete mini-protease inhibitor (Roche Diagnostics) for 10 sec using a 
polytron. The homogenate was centrifuged at 1,000g for 10 min at 4 °C yielding the 
nuclear fraction (Nuc) and the supernatant (Sup). The supernatant was centrifuged at 
31,000g for 5 min at 4°C using a discontinuous Percoll gradient. The layer between 
3% and 10% of Percoll were collected, washed in 30 ml of homogenization buffer 
and further centrifuged at 22,000 × g for 15 min at 4°CT. The pellet was resuspended 
in lysis buffer for RNA extraction (GenElute Mammalian Total RNA Miniprep Kit, 
Sigma).  
 
RNA extraction  
RNA was extracted using a GenElute Mammalian Total RNA Miniprep Kit (Sigma, St 
Louis, MO, USA) according to the manufacturer's instructions. Total RNA was 
quantified by absorbance spectroscopy and RNA integrity and quality was assessed 
by 1.0% agarose gel electrophoresis 
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Transcriptome analysis!
For transcriptome analysis using RNA-Seq, the quality of the isolated RNA was 
determined with a Qubit® (1.0) Fluorometer (Life Technologies, California, USA) and 
a Bioanalyzer 2100 (Agilent, Waldbronn, Germany). RNAs were then processed 
using The TruSeq Stranded mRNA Sample Prep Kit (Illumina, Inc, California, USA) 
according to the manufacturer recommendations. The TruSeq SR Cluster Kit v3-
cBot-HS or TruSeq PE Cluster Kit v3-cBot-HS (Illumina, Inc, California, USA) was 
used for cluster generation using 8 pM of pooled normalized libraries on the cBOT. 
Sequencing was performed on a Illumina HiSeq 2000 system using the TruSeq SBS 
Kit v3-HS (Illumina, Inc, California, USA) with paired end 2 X100 reads or single end 
1X100 reads. 
 
RNA-seq reads were quality-checked with fastqc which computes various quality 
metrics for the raw reads. Reads were aligned to the genome and transcriptome with 
tophat v 1.3.3. Before mapping the low quality ends of the reads were clipped (3 
bases from the read start and 10 bases from the read end). Tophat was run with 
default options. The fragment length parameter was set to 100 bases with a standard 
deviation of 100 bases. Based on these alignments the distribution of the reads 
across genomic features was assessed.Isoform expression was quantified with the 
RSEM algorithm (http://www.biomedcentral.com/1471-2105/12/323) with the option 
for estimation of the read start position distribution turned on. !
For rhythmicity detection in transcript profiles we used a non-parametric test, 
JTK_CYCLE (Hughes et al., 2010). 
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Abstract 
 
Subcellular localization of mRNAs plays an important role for regulation of local 
protein synthesis, especially in the context of development and neuronal plasticity. In 
recent years specialized RNA-binding proteins have been identified and functionally 
characterized such DBHS proteins, consisting of three homologous proteins NONO, 
PSPC1 and SFPQ, each of which contains two RNA recognition motifs (RRMs). 
DBHS proteins are nuclear proteins forming homo- and heterodimers in vivo, and 
have been previously described in various aspects of RNA production such as 
transcriptional activation and repression, splicing, pre-mRNA processing and RNA 
transport in neurons and other cell types. Additionally, they are major components of 
nuclear paraspeckles, where they associate with the long noncoding RNA Neat1 
which have been recognized as nuclear RNA-holding structures for edited RNAs. 
While the role of DBHS proteins in transcriptional regulation is known, its function in 
regulating synaptic morphology and function is up to now unclear. Here we 
demonstrate, that overexpression of all three NOPS proteins alters synaptic structure 
in primary neurons and mutations in its RNA recognition site have the opposite effect 
upon gephyrin clustering. Additionally, the RNA binding proteins NONO and PSPC1 
are highly expressed in the mouse hippocampal pyramidal neurons and dentate 
gyrus, where they particularly affect inhibitory synapse morphology by regulation the 
postsynaptic scaffolding molecule gephyrin as well as the GABRA2 receptor. 
Furthermore, examination of GABAergic synaptic structure in Neat1 knockout mice 
showed strong increase in numerical density of gephyrin as well as GABAA receptor 
alpha2 clusters in in the CA3 region of the hippocampus. Transcriptional analysis of 
the hippocampus of NONO and PSPC1 deficient mice showed specific regulation of 
the GABA receptor alpha2 subunit transcript in a circadian fashion. However, we 
were unable to trace these changes in transcription in Neat1 deficient neurons. 
Concluding, this study demonstrates the involvement of the DBHS protein family in 
inhibitory synaptic biology and suggests new role for paraspeckles, a nuclear sub-
compartment, which is built on the long-nocoding RNA Neat1. !!!
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Introduction 
 
Activity dependent synaptic changes are required for memory formation and storage 
in the brain described by the models of long-term potentiation (LTP) and long-term 
depression (LTD)! (1). A considerable aspect of this synaptic plasticity is determined 
postsynaptically by regulating the localization and the density of neurotransmitter 
receptors. It has now become evident that protein translation is required for the late 
phase of LTP and intermediate stages of LTD are dependent on new protein 
translation being independent of transcription!(2). This compartmentalization between 
mRNA synthesis and translation of proteins, which are present in a repressed phase 
allows fast rapid local response to a certain stimuli.  
 
The ability of mRNAs to move in the cytoplasm of eukaryotic cells is essential for 
sorting sites of synthesis for specific proteins. Studies analysing the mechanisms of 
mRNA localization have demonstrated the existence of complex mRNA transport 
systems (3). These and other studies have provided strong support for the idea that 
localized mRNAs are actively transported on cytoskeletal filaments. Two components 
of such RNA transport granules are NONO and SFPQ, members of the NOPS family 
of RNA-binding proteins (4).! This family consists of three homologous proteins 
NONO, PSPC1 and SFPQ, each of which contains two RNA recognition motifs 
(RRMs) (5-7). NONO (also known as p54nrb in humans) has been shown to regulate 
a variety of processes which include transcriptional activation and repression (8-10), 
pre-RNA processing(11-13), and RNA transport (4). For example, it has been shown 
to regulate the transcriptional activation of the TORC family of growth and metabolic 
factors (8). In an apparently unrelated nuclear function, it also mediates the nuclear 
retention of edited RNAs in nuclear paraspeckles, RNA holding structures (14, 15). 
These structures contain the related factors NONO, SFPQ, and PSPC1, as well as 
the noncoding scaffolding RNA Neat1!(6, 14-20). In addition, they have been found to 
play an important role in the circadian clock, where they might act as transcription 
factors! (21). While the role of NONO and other DBHS proteins in transcription and 
circadian clock regulation is known, its function in synapse morphology and function 
is up to now unclear.  
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An important component of the macromolecular complex at inhibitory synapses is 
Gephyrin, a highly conserved multifunctional protein also responsible for 
molybdenum cofactor synthesis! (22). In neurons Gephyrin is found co-localizing 
exclusively with GABAergic and glycinergic synapses and loss of Gephyrin 
expression results in a loss of GABAergic synaptic transmission. (23, 24) While direct 
interaction between gephyrin and glycine receptor beta subunit is well established, 
direct interaction with GABAA receptor subunit is except for the alpha2 subunit still 
unclear. Many gephyrin interacting protein have been identified, that includes some 
of the prominent members of the cytoskeleton binding proteins.  !
A previous study (Mircsof et al.) has shown that shown, that NONO regulates 
inhibitory synaptic biology. To better understand the underlying mechanism, in this 
study we investigated the role of DBHS proteins and nuclear paraspeckles on 
inhibitory synaptic morphology. Mechanistically, over-expression of DBHS proteins in 
primary rat neurons induced changes in the numeric density of gephyrin in a RNA 
motif dependent manner. 
 
Results 
 
NONO and PSPC1 are highly expressed in the nucleus of pyramidal cells and 
granule cells of the mouse hippocampus 
 
To study the distribution and localization of NONO and PSPC1 protein in the mouse 
brain, immunohistochemical staining were performed using antibodies validated 
using tissues lacking NONO or PSPC1 respectively (Supplementary Fig. 1) By 
immunofluorescence, NONO and PSPC1 were detected widely in brain including 
hippocampus and cortex (Figure 1C). Expression for NONO as well as PSCP1 was 
detected most strongly in the nucleus of NeuN positive neurons in CA1 and CA3 
pyramidal neurons and in granule cells of the dentate gyrus, which exhibited high 
levels. Additionally NONO and PSPC1 positive cells were also detected sparsely in 
CA1 and CA3 Stratum radiale and Stratum oriens, which were positive for NeuN. In 
the neocortex, NONO and PSPC1 were again most strongly expressed by neurons, 
particularly in layer II/III and V showing selective expression in NeuN but not GFAP 
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positive cells. However, NONO immunofluorescence was also detected in layer I of 
the cortex which were NeuN and GFAP negative, which resemble most likely 
oligodendrocytes (Figure 1B). Finally, morphological analysis of NONO and PSPC1 
distribution show complete colocalization between both proteins (Figure 1C). 
Altogether, its cellular localization and expression profile indicate that NONO and 
PSPC1 operate mainly in neurons of CA1 and CA3 pyramidal cells and dentate gyrus 
granule cells of the hippocampus. 
 
Supplementary Figure 1: Immunofluorescence 
labeling of NONO in wildtype NONO knockout 
(bottom) mouse coronal brain sections and PSPC1 in 
wildtype PSCP1 knockout (bottom) mouse coronal 
brain sections in CA3 region of the hippocampus. 
Scale bar = 100µm. 
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Figure 1.Cell type and layer-specific localization of NONO and PSPC1 in mouse brain. (A) 
Staining of hippocampal cell nuclei by DAPI (blue), anti-NONO (green), and neuron-specific anti-NeuN 
or astrocyte-specific anti-GFAP (red, left or right column respectively). (B) Identical staining of cortex 
Scale bar 100µm (C) Immunofluorescence labeling of NONO (green) and PSPC1 (red) in wildtype 
mouse coronal brain sections of the hippocampus. NONO and PSPC1 show strong immunoreactivity 
of principal neurons of the pyramidal cell layer (PCL) and the dentate gyrus (DG). (C5-7) Magnification 
of CA3 region of the mouse hippocampus labeled for NONO and PSCP1. Scale bar 200µm.  
 
DBHS protein regulates inhibitory synapse structure by the RNA binding 
domain 
 
Because of the involvement of the NOPS family of proteins in RNA transport in 
neurons and because they formed specific RNA holding structures in the nucleus, we 
guessed that these proteins might play a role in postsynaptic structure, perhaps 
through regulated RNA transport. To investigate whether these proteins might play a 
specific role in dendritic structure, we focused on gephyrin, which is a major 
scaffolding protein at inhibitory synapses in the CNS. Previous research has shown, 
that overexpression of the inhibitory scaffolding gephyrin in primay rat neurons 
localizes to endogenous postsynaptic inhibitory sites and does not affect 
morphological or functional properties of the transfected cell, thus enabling the use of 
GFP tagged gephyrin as an inhibitory marker (89). 
 
To better understand the role of DBHS protein regulating inhibitory synapse 
structure, vectors expressing mCherry tagged DBHS proteins were co-transfected 
into cultured primary rat hippocampal neurons together with eGFP-tagged gephyrin 
at 8 days in vitro (DIV8). Postsynaptic gephyrin clusters were identified by 
& & Results&
! 41&
immunofluorescence staining to directly visualize and quantify the distribution of 
gephyrin clusters 7 days later (DIV8+7) on the basis of colocalization with 
presynaptic vGAT. Analysis of gephyrin clusters in dendrites of cells expressing 
mCherry-NONO and mCherry-SFPQ showed significant increase in eGFP-gephyrin 
density compared to eGFP-gephyrin transfected neurons, while overexpression of 
mCherry-PSCP1 significantly reduced eGFP-gephyrin density (Figure 2). 
 
Hirokawa and co-workers have shown, that NOPS proteins bind RNA using their 
RNA recognition motif (RRM) and regulate mRNA localization (134) and thereby 
potentially regulate inhibitory morphology through their RRM motif. To answer this 
hypothesis, DBHS constructs containing 4 point mutations in their RNA recognition 
motif, disrupting RNA binding, were co-expressed with GFP-Gephyrin in analogy to 
the previously described assay. Interestingly, over expression of the mutated DBHS 
constructs had the opposite effect on gephyrin density as it has been show for the 
wildtype construct (Figure 2). This results suggest, that gehpyrin oligomerization at 
inhibitory synapse is regulated by the RNA binding property of the DBHS proteins. 
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Figure 2. Primary hippocampal rat neurons expressing control GFP-gephyrin alone, or co-expressed 
with myc-DBHS proteins, or co-expressed with RNA binding-deficient myc-DBHS-RRM. Boxed region 
is magnified beneath. Postsynaptic clustering is demonstrated by apposition of eGFP-gephyrin 
clusters (green) to vGat -positive terminals (blue). Scale bar 20µm.  
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GABRA2 and gephyrin cluster densitiy are reduced in the hippocampus of 
NONO knockout mice 
 
To investigate whether NONO proteins plays a specific role in dendritic inhibitory 
structure in-vivo, cytological studies were performed using antibodies against native 
gephyrin and GABA-A Receptor α2 subunit of brain sections from wildtype, NONO 
and PSPC1 deficient mice. The CA3 area of the hippocampus is a brain region with 
distinct synapse distribution conditional to specific layers. For our confocal images 
we decided to analyse the strata radiatum, because other regions with high density of 
clusters precluded determining their numbers. Analysis in the CA3 region of the 
hippocampus showed, that gephyrin and GABA-A Receptor α2 subunit as 
postsynaptic markers are significantly reduced (30.7% and 35.1% respectively) in 
NONO KO mice while PSCP1 deficient neurons show significant increased gephyrin 
(39.1%) and GABAAR α2 (12.3%) density (Figure 3 and 4). Size of synaptic gephyrin 
and GABA-A Receptor α2 subunit were however not affected by NONO or PSPC1 
deficiency (Figure 3 and 4). In general, vGAT positive terminals in the Hippocampus 
could be shown to be distributed around pyramidal cells, however throughout the 
examined brain regions vGAT staining was found to be inconsistent, suggesting 
weak antibody-stability. 
 
Both ribonucleoproteins NONO and PSPC1 are a part of the nuclear sub-structure 
called paraspeckle, which are built on the long non coding RNA (lncRNA) NEAT1. To 
test the hypothesis, that this specific structure is involved in inhibitory morphology, 
we performed immunohistological studies of brain sections from wildtype and Neat1 
deficient mice, using antibodies against the GABA-A Receptor α2 subunit, as well as 
the synaptic scaffolding protein gephyrin as previously described. Interestingly, 
hippocampi from Neat1 deficient mice showed a significant increase in the numeric 
density of the inhibitory marker gephyrin (40.2%) and GABA-A Receptor α2 subunit 
(23.6%) (Figure 5). Again, the average cluster size of these markers was not affected 
in Neat1 deficient mice compared to wildtype littermates (Figure 5). Overall analysis 
of gephyrin, GABA-A Receptor α2 subunit and vGAT immunoreactivity expressed in 
the GABAergic interneurons in the CA3 layer of the hippocampus regions revealed 
that paraspeckle depletion causes profound reduction of gephyrin and GABAAR α2 
clustering at postsynaptic sites. 
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Figure 3. Effects of NONO deficiency upon synaptic biology. Immunohistochemical staining for 
inhibitory postsynaptic marker gephyrin (green), GABA type II receptor (red), and the presynaptic 
marker vGat (blue) in wildtype and NONO KO mice in the stratum radiatum CA3 of the hippocampus 
(top). Scale bar 25µm. Quantification of gephyrin and GABA type II receptor density (left) and cluster 
size (right). Means ± SD are shown, *P < 0.05 using Student’s t-test (top). n = 3 mice per genotype 
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Figure 4. Effects of PSPC1 deficiency upon synaptic biology. Immunohistochemical staining for 
inhibitory postsynaptic marker gephyrin (green), GABA type II receptor (red), and the presynaptic 
marker vGat (blue) in wildtype and PSPC1 KO mice in the stratum radiatum CA3 of the hippocampus 
(top). Scale bar 25µm. Quantification of gephyrin and GABA type II receptor density (left) and cluster 
size (right). Means ± SD are shown, **P < 0.005 using Student’s t-test (top). n = 3 mice per genotype. 
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Figure 5. Effects of Neat1 deficiency upon synaptic biology. Immunohistochemical staining for 
inhibitory postsynaptic marker gephyrin (green), GABA type II receptor (red), and the presynaptic 
marker vGat (blue) in wildtype and Neat1 KO mice in the stratum radiatum CA3 of the hippocampus 
(top). Scale bar 25µm. Quantification of gephyrin and GABA type II receptor density (left) and cluster 
size (right). Means ± SD are shown, *P < 0.05 using Student’s t-test (top). n = 3 mice per genotype. 
 
 
NONO and PSPC1 regulate GABRA2 mRNA levels in-vivo 
 
Since DBHS proteins have been described in transcriptional regulation!(113,(115,(154) 
as well as the circadian clock! (91), it is essential to separate these two processes. 
For this, we have investigated the transcription of GABAergic synaptic components in 
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mouse brain around the clock. For this, wildtype mouse brains were harvested over 
the period of 24h in constant dark conditions and inhibitory transcripts were analyzed 
by qPCR. Transcription profiles of key GABAergic regulatory molecules revealed that 
GABA-A Receptor α2 subunit was expressed in a circadian fashion (p=0.016), while 
GABAAR α1 (p=0.82), Collybistin (p=0.1) or Gephyrin (p=0.33) showed significant 
alterations (Figure 6).  
 
 
Figure 6. Expression analysis of inhibitory synaptic components around the clock. mRNA 
expression profile for inhibitory synaptic gene components at circadian timepoint (CT) 0-20 by RT-
PCR. Gene expression levels were normalized to beta-Actin and CT0. n = 3 mice per genotype. 
Means ± SD are shown.  
 
 
Thus, we further focused on the expression levels of these molecules at circadian 
timepoints (CT) 10 and 22, since GABA-A Receptor α2 peaked at these timepoints. 
Again, components of GABAergic inhibitory synapses such as gephyrin, collybistin 
and GABRA2 were compared in wildtype, NONO and PSPC1 deficient hippocampi. 
Transcriptional analysis showed, that gephyrin, collybistin and GABRA1 was not 
affected in NONO and PSPC1 deficient neurons (Supplementary Figure 2).  
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Supplementary Figure 2: mRNA expression profile for inhibitory synaptic gene components at 
circadian timepoint (CT) 10 and 20 by RT-PCR in wildtype (white), NONO knockout (top, black) and 
PSPC1 knockout (black, bottom) hippocampal samples. Gene expression levels were normalized to 
beta-Actin and CT10. Means ± SD are shown. n = 3 mice per genotype 
 
Analysis of GABRA2 transcript levels at CT10 and CT22 showed significant 
differences as expected from the previous circadian profile. Interestingly, mice 
lacking NONO, showed a striking reduction of GABRA2 at both circadian timepoints, 
while PSCP1 depleted hippocampi showed a significant increase at CT10 but not at 
CT10 (Figure 7), indicating a possible role of PSPC1 but not NONO in the circadian 
transcription of GABRA2. Since the morphological inhibitory synaptic defects could 
potentially created/generated by disturbed transcription of the the GABA-A Receptor 
α2 subunit, we tested GABRA2 mRNA levels in Neat1 deficient mice as previously 
described. Unfortunately, qPCR analysis could not identify any significant differences 
of GABRA2 levels between wildtype and Neat1 KO mice (Figure 7), indicating a more 
complex underlying mechanism. However, it has to be noted, that GABRA2 mRNA 
levels did not change significantly between CT10 and CT22 as previously expected. 
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Figure 7. GRABR2 mRNA expression levels in the mouse 
hippocampus. Quantification of GABRA mRNA levels in the 
mouse hippocampus in wildtype (white), NONO knockout (blue), 
PSPC1 knockout (red) and Neat1 knockout (green) mice by RT-
PCR at circadian timepoint (CT) 10 and 22. GABRA2 
expression levels were normalized to beta-Actin and CT10. 
Means ± SD are shown, *P < 0.05 using Student’s t-test (top). n 
= 3 mice per genotype 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
While the role of DBHS proteins in transcriptional regulation is known, its function in 
regulating synaptic morphology and function is up to now unclear. Here, we have 
demonstrated the involvement of thes proteins in inhibitory morphology and postulate 
a new function for nuclear paraspeckles. NONO and PSCP1 are highly expressed in 
neurons of the mouse hippocampus und modulate clustering of GABA-A Receptor α2 
subunit as well as gephyrin, a key scaffolding molecule at inhibitory synapse. NONO 
and SFPQ, another DBHS protein family member, together with PSP1, localize to so 
called nuclear paraspeckles! (14, 15, 17-19, 26). These ribonucleoprotein structures, 
built on the long non-coding RNA (lncRNA) NEAT1 and elimination of Neat1 leads to 
the disruption of paraspeckles!(14, 18-20). 
  
To support the hypothesis, that DBHS modulate inhibitory synaptic structure by their 
localization to paraspeckles, our immunocytological studies show, that elimination of 
the essential paraspeckle component Neat1 leads to increased gephyrin and GABA-
A Receptor α2 subunit density in analogy to PSPC1 deficient neuron. Additionally, 
while NONO depletion lead to reduced GABRA2 mRNA levels, PSPC1 deficiency 
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shows the opposite effect. This phenomenon could be explained by two hypothetical 
models which have been previously demonstrated for the DBHS proteins: In the first 
case, both NONO and PSCP1 compete as negative transcription factors with 
different repressive potentials for GABRA2 repression, in which NONO would be a 
weaker repressor compared to PSPC1 (8, 27, 28). In a second model, NONO would 
act as a positive transcription factor, while PSPC1 inhibits the transcription of 
GABRA2 (9, 29-31).  
 
In contrast to NONO and PSPC1 KO mice, Neat1 knockout mice did not show 
transcriptional deregulation of GABRA2 mRNA levels in the hippocampus, indication 
that both NONO/PSCP1 might affect GABRA2 levels independently of the 
paraspeckle. However, recent studies added a new layer of complexity taking the 
nubnuclear localization of DBHS proteins into account (32, 33). In this model, the 
fraction of DBHS proteins bound to paraspeckles through Neat1 and nucleoplasmic 
DBHS proteins are in homeostasis. For example, disruption of Neat1 leads to 
significant increase of freely available DBHS proteins and thereby might enhance 
gene transcription by promoter binding.  
 
Therefore, we hypothesize that mechanistically nuclear enriched Neat1 regulates 
either synaptic gene expression and/or retention by modulating the differential 
association or activity of DBHS proteins from promoter regions to paraspeckles. In 
order to distinguish translation and nuclear retention, gene expression analysis in 
nuclear as well as synaptosomal fractions of NONO, PSPC1 and Neat1 deficient 
mouse brains should shed light into this open question. 
 
Previous studies have shown a strong association of the hippocampus and the 
inhibitory system in memory and anxiety (34). Considering the strong expression of 
NONO and PSPC1 in the mouse hippocampus, where they regulate GABAergic 
inhibitory morphology additional functional studies by electrophysiology as well as 
behavioral can help to better understand the functional implication of paraspeckles in 
the brain. 
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Material and Methods 
 
Plasmids 
The eGFP–gephyrin P1 variant has been described previously (Lardi-Studler et al., 
2007). Overexpression of myc-DBHS and myc-DBHS RRM, were conducted using 
the plasmids described in Kuwahara et al.  
 
Cell culture 
Primary hippocampal neuron cultures were prepared as described previously (Buerli 
et al., 2007). Hippocampal cultures were transfected with 0.5 µg of either eGFP–
gephyrin or the specific myc–NONO construct according to the protocol described 
previously (Buerli et al., 2007). Cells were transfected after 8 DIV and processed for 
immunofluorescence 7 days later (referred to as 8+7 DIV). In co-transfection 
experiments the total DNA concentration was maintained at 1.5 µg. 
 
Mice 
Generation of NONO and Neat1 knockout mice was described previously in. (139, 
163). Chimeric mice were obtained from PSPC1gt ES cells (C57Bl6 genotype) via 
standard blastocyst injection into SV129 mice by the University of California, Davis. 
Individual chimeric mice were back-crossed 4–10 generations against C57Bl6 All 
experiments were performed by comparing adult wild type and mutant littermates (2-
3 months old). Animal housing and experimental procedures are in agreement with 
veterinary law of the canton of Zurich. For circadian experiments, mice have been 
housed in constant darkness. 
 
RNA extraction and quantitative real-time PCR analysis 
RNA was extracted using a GenElute Mammalian Total RNA Miniprep Kit (Sigma, St 
Louis, MO, USA) according to the manufacturer's instructions. Total RNA was 
quantified by absorbance spectroscopy and RNA integrity and quality was assessed 
by 1.0% agarose gel electrophoresis. Total RNA (1 µg) was transcribed to cDNA with 
SuperScript II (Invitrogen, Carlsbad, CA, USA) using random hexamer primers 
according to the manufacturer's instructions. For quantitative real-time PCR (qPCR), 
20 ng of cDNA was used, and single transcript levels of genes were detected with the 
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HOT FIREPol EvaGreen qPCR Mix (Solis BioDyne, Tartu, Estonia) and an AB7900 
thermocycler. Primers used for detection of synaptic transcripts were as follows:  
 
βUActin&Fwd& AGTGTGACGTTGACATCCGTA&
βUActin&Rev& GCCAGAGCAGTAATCTCCTTCT&
GABRA1&Fwd& GGTTGACCGTGAGAGCTGAA&
GABRA1&Rev& CTACAACCACTGAACGGGCT&
pan&Collybistin&Fwd& CAATGATGATCCCCACCTCAGT&
pan&Collybistin&Rev& AGTGTTGATAGCGGCTGTCCTT&
GABRA2&Fwd& CAGTGGCCCATAACATGACAAT&
GABRA2&Rev& GGACATTCGGCTTGGACTGT&
Gephyrin&Fwd& GGCGACCGAGGGAATGAT&
Gephyrin&Rev& CCACCCAACAAAGAAGGATCTT&
 
Data were analyzed using the comparative CT method (Schmittgen & Livak, 2008). 
 
Immunohistochemistry  
Mouse anti-gephyrin antibody (mAb7a, 1:3000; or 3B11, 1:10000; Synaptic Systems, 
Gottingen, Germany), rabbit anti-vGAT antibody (1:3000, Synaptic Systems, 
Gottingen, Germany), guinea pig anti-GABAAR α2 subunit antibody (Fritschy and 
Mohler, 1995), mouse anti-Myc (1:10000, Roche), rabbit anti-NONO (1:500, Brown, 
2011), mouse anti-PSPC1 (1:500; SAB4200503 Sigma-Aldrich), NeuN (1:1000; 
MAB377 Milipore), GFAP (1:1000, Z0334 DAKO and MAB360, Millipore) and 
secondary antibodies coupled to Cy3 or Cy5 (1:500-1000, Jackson 
ImmunoResearch). 
Immunocytochemistry on cells was performed as described previously (Tyagarajan 
et. Al 2011). In short, cells were rinsed in PBS and fixed for 10 minutes in 4% 
paraformaldehyde at room temperature. Cells were permeabilized with 0.01% Triton 
X-100 and detection of intracellular proteins were achieved by incubation for 60 
minutes at room temperature with primary antibodies diluted in PBS containing 10% 
normal serum, followed by incubation with secondary antibodies coupled to Cy3 or 
Cy5 (1:500, Jackson ImmunoResearch) for 30 minutes at room temperature. Finally, 
coverslips were mounted with fluorescent mounting medium (Dako Cytomation, 
Carpinteria, CA). The GABAARα2 subunit antibody was incubated in living cultures 
for 90 minutes in culture medium (Brünig et al., 2002) 
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Staining and immunhistochemical analysis of synaptic components was performed 
as previously described (Notter et. al., 2013). Briefly, mice were anesthetized with 
pentobarbital and perfused intracardially with ice-cold, oxygenated ACSF. The brain 
was extracted and cut in blocks containing the regions of interest for analysis (e.g. 
hippocampal formation). The Tissue was plunged into ice-cold, freshly prepared 
fixative (4% PFA in PBS) and postfixed for 90 min, rinsed with phosphate-buffered 
saline (PBS), cryoprotected overnight in 30% sucrose in PBS and frozen with 
powdered dry ice and stored at –80 °C. 
Sections were cut from frozen blocks with a sliding microtome at a thickness of 
40 µm and were collected free-floating in PBS. They were incubated under 
continuous agitation in primary solution (Tris buffer (pH 7.4) containing 0.2 Triton X-
100, 2% normal serum and the primary antibodies) for 15–48 h at 4 °C, washed in 
Tris buffer and incubated for 30–60 min at room temperature in secondary antibodies 
coupled to a fluorochrome. 
 
Image analysis 
Immunofluorescence images were captured by laser scanning confocal microscopy, 
using a 20x, 40x or 64x lens respectively (NA 1.4, 1024 x 1024 pixels, Zeiss LSM 
710). Final illustrations were prepared from the maximal intensity projection of stacks 
of images spaced at 0.5 µm. Signals were quantified, using a custom macro created 
with the ImageJ software. Images were back- ground-subtracted and filtered with a 
Gaussian filter, but no change in brightness and contrast was applied.  
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Abstract 
 
Identifying causes of sporadic intellectual disability remains a considerable medical 
challenge. Here, we demonstrate that null mutations in the NONO gene, a member of 
the Drosophila Behavior Human Splicing (DBHS) protein family, are a novel cause of 
X-linked syndromic intellectual disability. Comparing patients to Nono-deficient mice 
revealed related behavioral, craniofacial, and transcriptional anomalies. In brain, 
these mice also showed deregulation of a large number of synaptic transcripts 
including the GABA receptor alpha2 subunit, as well as impaired postsynaptic 
scaffolding of gephyrin, a master organizer of inhibitory synapses. Importantly, 
alteration of synaptic scaffolding could be rescued by over-expression of Gabra2 in 
NONO-compromised neurons, suggesting that aspects of this syndrome are 
potentially treatable. Our data identify NONO as a new neurodevelopmental-disease 
gene and highlight the key role of DBHS proteins in functional organization of 
GABAergic synapses. 
 
Results 
 
Intellectual disability (ID) is characterized by significant limitations in intellectual 
functioning and adaptive behavior. Recent developments in next-generation 
sequencing (NGS) and whole-exome sequencing (WES) have considerably 
empowered detection of disease variants in ID (1-3). WES was carried out in parallel 
in two unrelated male ID patients (MCCID1 and 2), who presented the same slender 
built-macrocephaly gestalt, facial features, shy behavior, a thick corpus callosum!and 
a smaller cerebellum (Fig. 1a and 1b, Table S1 and Supplementary Note). 
Hypothesizing that the same disease gene was shared by the two patients, only the 
X-linked NONO (Non-octamer-containing, POU-domain DNA-binding protein, also 
known as p54NRB) gene emerged as a candidate (Supplementary Table 2). 
Capillary sequencing confirmed the de novo occurrence of a splice site variant 
affecting the last base of exon 10 in patient MCCID1 (NM_001145408.1:c.1131G>A; 
p.Ala377Ala) (Supplementary Fig.1). The variant identified in patient MCCID2 was a 
one-base-pair insertion in the last coding exon (NM_001145408.1:c.1394dup ; 
p.Asn466Lysfs*13) inherited from his healthy mother (Supplementary Fig.1). 
Immunoblot analyses of cultured skin fibroblast lysates using an anti-NONO antibody 
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showed a markedly reduced amount of NONO proteins in patient cells compared to 
controls (Fig 1c, d). These results were confirmed by immuno-cytochemistry using 
the same antibody (Fig. 1e).  
 
NONO belongs to the highly conserved Drosophila Behaviour Human Splicing 
(DBHS) protein family. This family includes three members in mammals, namely 
NONO, paraspeckle component 1 (PSPC1), and Splicing Factor Proline/Glutamine-
Rich (SFPQ, also known as PSF). DBHS proteins are nuclear proteins forming 
homo- and heterodimers in vivo (4,5) and previous literature documents their 
involvement in various aspects of RNA production (6). Studies in vitro suggest that 
they play a role in transcriptional activation and repression (7-9), splicing (10,11), 
pre-mRNA processing (12) and RNA transport (13,14). In addition, they are major 
components of nuclear paraspeckles, which have been recognized as nuclear RNA-
holding structures for edited RNAs (15,16) that likely play a role in stress-mediated 
regulation via nuclear retention of transcripts (17-19). NONO and other DBHS family 
members also serve as transcriptional cofactors for correct circadian clock function in 
both flies and mammals, where they regulate the circadian clock via interaction with 
PER proteins (20-23). However, no study so far has linked impaired function of these 
proteins to human disease. 
 
Consistent with the established role for the NONO protein within the circadian clock, 
cultured skin fibroblasts from patients showed reduced amplitude of circadian 
oscillations (Supplementary Fig. 2). Microarray analysis of cultured skin fibroblast 
RNAs in patients compared to controls also revealed a marked modification in the 
global pattern of gene expression between the two groups. Indeed, hierarchical 
clustering analysis showed that the patient group formed an independent cluster 
away from the control RNAs, as illustrated by the corresponding heatmap (Fig. 2a). A 
total of 389 differentially expressed genes were shared by the two patients with 372 
transcripts being similarly affected (213 down regulated and 159 up regulated), 
whereas only 17 transcripts were deregulated in opposite orientation (Fig. 2b, 
Supplementary Table 3). Notably, increased levels of PSPC1 (2.22 and 2.78 fold 
respectively) and SFPQ transcripts (1.54 and 1.71 fold respectively) were detected in 
patients compared to controls. Expression data were confirmed by Western blot 
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analysis showing increased amounts of PSPC1 and SFPQ proteins in patient 
fibroblasts compared to controls (Fig 1c,d).  
 
To further characterize the physiological role of NONO upon brain development, we 
analyzed a mouse model in which the Nono gene had been disrupted by genetrap 
(gt)23. Visual inspection and CT scan revealed that mutant mice displayed a 
flattened nose mimicking the facial anomalies observed in the patients (Fig. 3a-c, 
Supplementary Table 4). Similarly, a smaller cerebellum was observed in mutant 
mice (Fig 3d, S2, Supplementary Table 4) and patients (Fig. 1b, Supplementary 
Table 1), as well as other structural anomalies (Supplementary Fig. 3, 
Supplementary Table 1, 4). Behaviorally, mice showed impaired performance in the 
Morris Water Maze (Fig 3e,f) reflective of the cognitive defects observed in patients, 
as well as a marked anxiety phenotype documented via prepulse inhibition, open 
field exploration, and light-dark preference testing (Supplementary Fig. 4). Gene 
expression analysis in adult dermal fibroblasts from wild type and Nonogt mice also 
revealed global transcriptional deregulation in the mutant mice compared to controls 
in patterns similar to that of human patients and controls. When human and mouse 
data sets were merged and submitted to a hierarchical clustering with the Spearman 
correlation similarity measure, the samples were split in two main groups. Nonogt 
mice samples segregated with the patients group, whereas wild type mice samples 
segregated with the human control samples (Fig. 2c and Supplementary Table 5). 
Taken together, these data demonstrated a regulatory role of NONO conserved 
through evolution and supported the relevance of the Nonogt model for further 
elucidation of the disease mechanism in patients. 
 
Immunofluorescence analysis using anti-Nono antibodies detected strong 
immunoreactivity in mouse brain, including cortex and hippocampus (Fig. 4a). 
Staining was strongest in neuronal nuclei (NeuN-positive) in CA1 and CA3 pyramidal 
regions and granule cells of the dentate gyrus, but absent from neighboring 
astrocytes (GFAP-positive) (Supplementary Fig. 5). Gene expression analysis in 
hippocampi of wildtype and Nonogt mice identified 882 differentially expressed genes 
(Fig. 4b), including the two other DBHS family members Sfpq and Pspc1 
(Supplementary Fig. 6), as observed in fibroblasts from NONO-deficient patients 
(Supplementary Table 3). Protein levels of these orthologs were also overexpressed 
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in Nonogt hippocampi (Supplementary Fig. 7). Interestingly, mRNA levels of Gabra2, 
the GABAA receptor alpha2 subunit, were markedly reduced in hippocampi of 
Nonogt mice compared to controls, a result confirmed by qRT-PCR and Western blot 
analyses (Supplementary Fig. 6,9). Finally, pathway analyses suggested that NONO-
regulated genes were markedly enriched in Gene Ontology categories related to 
synaptic functions (Supplementary Table 5). To support this in silico prediction, we 
compared the synaptosomal transcriptomes from Nonogt and control mice. RNA was 
extracted from synaptosomal fractions obtained by density gradient 
ultracentrifugation (24). The quality of this fractionation was confirmed by verifying 
enrichment of known synaptically transported RNAs and depletion of known nuclear 
RNAs relative to whole transcriptome (Fig S7A-C). We found that 30.5% of 
synaptosomal transcripts, including Gabra2 (Fig S6D), were deregulated in samples 
from Nonogt mice when compared to controls, a significant over-representation 
compared to whole transcriptome (Table S6, p=0.0007). Hence, our data suggest 
that NONO might play an important role in the regulation of synaptic RNAs. 
 
Gabra2 codes for a subunit of the GABAA receptors that potentiate the majority of 
fast synaptic inhibition in the brain. Previous studies have demonstrated that GABAA 
receptors are anchored postsynaptically by gephyrin, which self-assembles into a 
scaffold and interacts with the cytoskeleton. Gephyrin binding to GABAA receptors is 
mediated by interaction sites that have been mapped within the intracellular loop of of 
GABAA receptors α1, α2 and α3 subunits (25). We thus tested the consequences of 
loss of NONO at inhibitory synapses by immunohistological studies of brain sections 
from wild type and Nonogt mice, using antibodies directed against GABAAR α2 and 
gephyrin respectively. Post-synaptic punctate staining for gephyrin and GABAAR α2 
was significantly reduced in the CA3 hippocampal region of Nonogt mice, while 
staining of the presynaptic vesicular GABA transporter marker (VGAT) was 
unaffected (Fig. 4c). Quantitative evaluations showed that the number of gephyrin 
clusters was significantly reduced, but average cluster size was conserved (Fig. 4d). 
Western blot analyses showed markedly reduced GABAAR α2 levels in total brain 
lysates and synaptosomes (Supplementary Fig. 9). By contrast, gephyrin levels were 
similar in wild type and Nonogt in all compartments analyzed (Supplementary Fig. 9). 
Taken together, these data suggest that reduced GABAAR α2 levels in Nonogt mice 
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are likely due to transcriptional deregulation. On the other hand, altered gephyrin 
clustering is likely a downstream consequence of altered synaptic composition.  
 
In principle, the anomalies observed in Nonogt mice could arise from either cellular 
synaptic defects, or broader neurodevelopmental changes. To distinguish between 
these possibilities and uncover potential cell-autonomous phenotypes, we used high-
resolution fluorescent in situ hybridization to analyse dissociated hippocampal 
neurons from wildtype and Nonogt mice. As in intact brain slices, we observed a 
significant reduction of Gabra2 transcripts in Nono-deficient neurons but unchanged 
transcript levels for other postsynaptic markers (collybistin, Gabra1) (Supplementary 
Fig. 10). At the protein level, these cultures showed the same reduction of gephyrin 
scaffolding puncta and GABAAR α2 levels, demonstrating that primary culture 
neurons from these mice recapitulated the key cytological features observed in 
Nonogt mouse hippocampi. This cellular model was therefore used for functional 
analysis of NONO in post-synaptic biology. 
 
It has been previously established in cultured primary neurons that over-expression 
of green fluorescent protein-tagged gephyrin (GFP-gephyrin) has no apparent effect 
on gephyrin clustering. This tool was used to examine in more detail the effects of 
NONO upon post-synaptic structures (26). Inversely to what was observed in Nono-
deficient mouse neurons, over-expression of Myc-tagged NONO in wildtype primary 
hippocampal neurons expressing GFP-gephyrin caused a significant increase in 
density of GFP-gephyrin puncta compared to neurons transfected with GFP-gephyrin 
alone. By contrast, a reduction in GFP-gephyrin density was observed in cells 
transfected with a construct over-expressing a mutant form of the NONO protein, 
myc-NONO RRM (Fig. 4e,f). This construct contains four point mutations in the RNA 
recognition motif (RRM), and is therefore unable to bind to single-stranded RNAs. 
Thus, we can conclude that the function of NONO upon synaptic biology is RNA-
dependent. 
 
Gephyrin depends on the presence of GABAAR to form postsynaptic clusters in 
GABAergic synapses, and the size and density of gephyrin scaffolding can be 
correlated to strength and frequency of GABAergic transmission (25,26). Thus, 
gephyrin clustering is largely impaired in the mice lacking the GABAAR α2 subunit 
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(Gabra2-KO) (27). Therefore, we hypothesized that the altered gephyrin distribution 
observed in NONO-deficient neurons might be the consequence of Gabra2 transcript 
deregulation, and furthermore that this defect might be rescued by over-expressing 
GABAAR α2. Indeed, transfection of plasmids expressing Gabra2 could rescue the 
reduced gephyrin cluster density observed in cultured neurons transfected with myc-
NONO RRM (Fig. 4g,h), further supporting the view that NONO alters postsynaptic 
structure by regulating Gabra2 levels.  
 
Discussion 
 
In this study, we have shown that NONO-null mutations cause a novel, clinically 
recognizable ID syndrome, with slender built-macrocephaly, malar hypoplasia and 
thick corpus callosum. A mouse model deficient in NONO recapitulates the major 
features of this syndrome. Studying brains and neurons from these mutant mice 
suggested that NONO plays an unsuspected role in regulating inhibitory synaptic 
biology, results also consistent with intellectual and anxiety phenotypes of these 
mice. Previous studies have identified NONO as a member of a neuronal RNA 
transport complex (13) and demonstrated increased NONO abundance at synapses 
in response to synaptic activity (28), but no study has yet linked dysfunction in NONO 
or other DBHS proteins to any human disease. Our studies clearly demonstrate that, 
in the brain, NONO function is primarily mediated by its role in the regulation of RNA 
expression, and suggest that it may contribute to the local regulation of RNA 
metabolism underlying activity-dependent regulation of dendritic spine morphology. 
Finally, because inhibitory synapse structural defects caused by NONO dysfunction 
could be rescued by increasing the number of GABA-α2 receptors, this study opens 
reasoned opportunities for therapeutic trials in this novel intellectual disability 
syndrome.  
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Figure Legends 
 
 
 
 
Figure 1: P54NRB/NONO mutations and their functional consequences (a) 
Photographs and pedigree of both patients. Shaded symbols indicate the affected 
individuals. (b) Sagittal T1 and axial FSE T2 brain MRI of patient MCCID1 at 9 years-
old (left panel) and patient MCCID2 at 8 years old (right panel) showing a thick 
corpus callosum, a small cerebellum and a Chiari I malformation (arrows). (c) 
Immunoblots showing a complete absence of the NONO protein and overexpression 
of PSPC1 and SFPQ proteins in patients’ cells compared to controls. (d) 
Densitometry analyses. Means ± standard error (SEM) for the three DBHS proteins 
relative to the amount of total proteins are given from two independent experiment 
and expressed as a percentage of the control values (100%). Significance was 
calculated using two-way analysis of variance (ANOVA) test with Tukey correction. 
Here and in subsequent figures, * P value < 0.05, ** P value < 0.01, *** P value 
< 0.001 (e) Immunofluorescence showing the complete absence of the NONO 
protein in patients’ cells compared to controls.  
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Figure 2. Transcriptome analysis in human and mouse cells (a) Heatmap cluster 
analyses indicating similarity in expression profile among probes from the two 
patients and differences compared to the two controls. High detection signals relative 
to the mean were colored in red. Low detection signals were colored in green. The 
cut-off for inclusion in the heatmap was a 1.5-fold alteration of probe expression for 
both patients. (b) Venn diagram showing the number of genes commonly or 
differentially expressed in the two patients compared to the mean of the two controls. 
Significant differences are based on a 1.5-fold difference and a P-value of<.05. U= 
up, D= down. (c) Hierarchical clustering analysis of combined mouse and human 
orthologous genes, resulting in a striking separation highlighting similarity of mouse 
and human transcriptional dysregulation. 
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Figure 3. Functional consequences of NONO deficiency in mice. (a) Side 
view of representative Nonogt mouse (right) compared to wildtype littermate (left). 
(b) CTscan analysis indicating a flattened and distorted nose in Nonogt mice 
(right) compared to WT (left). (c) Quantification of skull length, width and nose 
length in Nonogt mice (black) compared to wildtype littermate (white). n = 20 mice 
per genotype. ***P < 0.001 ; Student’s t-test. Bars represent mean ± SD. (d) MRI 
scan of representative Nonogt mouse (right) compared to wildtype littermate (left). 
Yellow arrow indicates cerebellum. Also see Supplementary Fig 3 and 
Supplementary Table 4. (e-f) Behavior of Nonogt mice and WT littermates in 
Morris water maze, n=16-20 per genotype. Black circles, Nonogt; open circles, 
WT. Unless otherwise noted in this and subsequent figure, bars represent means 
± SEM. (e) Gallagher’s proximity test scores, i.e. average distance of mice from 
goal as fraction of total distance. Repeated ANOVA, gene p<0.0237, time 
p<0.001, gene x time n.s. (f) Whishaw’s error, i.e. % path outside an 18cm-wide 
corridor connecting release point and goal. Gene p<0.0215, time p<0.001, gene 
x time n.s.  
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Figure 4. Effects of NONO deficiency upon synaptic biology. (a) 
Immunofluorescence labeling of NONO in wildtype (top) and Nonogt (bottom) 
mouse coronal brain sections. PL = pyramidal cell layer, DG = dentate gyrus. (b) 
Scatter plot of hippocampal transcriptome from WT and Nonogt mice. Red, 
diffrentially expressed genes, p ≤ 0.01 and log ratio ≥ 0.5. (c) 
Immunohistochemical staining for inhibitory postsynaptic marker gephyrin 
(green), GABA type II receptor (red), and the presynaptic marker vGat (blue) in 
wildtype and Nonogt mice in the stratum radiatum CA3 of the hippocampus. (d) 
Quantification of gephyrin, GABA type II receptor and vGat density (left) and 
gephyrin cluster size (right). Means ± SD are shown, *P < 0.05 , **P < 0.01 ; 
Student’s t-test (top) and Kolmogorov-Smirnov test (bottom). (e-h) 
Immunofluorescence analysis of inhibitory synapse morphology in-vitro. (e) 
Primary hippocampal rat neurons expressing control GFP-gephyrin alone, or (e’) 
co-expressed with myc-NONO, or (e’’) co-expressed with RNA binding-deficient 
myc-NONO-RRM,. Boxed region is magnified beneath. Postsynaptic clustering is 
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demonstrated by apposition of eGFP-gephyrin clusters (green) to vGat -positive 
terminals (blue). (f) Quantification of cluster density distribution in 9 neurons from 
3 independent experiments., Control x NONO *P < 0.05, Control x NONO- RRM 
*P < 0.05 using Kolmogorov-Smirnov test. (g) Primary hippocampal rat neurons 
expressing control GFP-gephyrin alone, or (g’) co-expressed with myc-NONO-
RRM, or (g’’) co-expressed with myc-NONO-RRM and GABRA2. (h) 
Quantification, showing complete rescue of the impaired gephyrin cluster 
distribution by GABRA2. Control x NONO RRM *P < 0.05, Control x NONO RRM 
GABRA2 *P < 0.05 using Kolmogorov-Smirnov test. 
 
  
& & Results&
! 73&
Online Methods 
 
Patients 
 
All human protocols were reviewed and approved by the institutional review board of 
the Necker Hospital and informed consent was obtained from all subjects involved in 
this study.  
 
Case MCCID1 was the second child of healthy, nonconsanguineous parents. Family 
history is unremarkable. He was born in the 41st week of gestation, after a normal 
pregnancy and delivery and an Apgar score of 10/10. Parameters at birth were in the 
normal range (BW 3370g, LW 50.5 cm, HC 34 cm). Developmental milestones were 
delayed: he was able to walk alone at 3 years of age, and had limited speech with 
preserved comprehension. He developed absence seizures at the age of 5 years and 
continued to have seizures with increased frequency. He had strabismus and 
myopia. At the age of 15 years, he developed severe kyphoscoliosis. On examination 
at 17.5 years, his height was 1.79 m (+1SD), his weigh 50 kg (-1.5SD), and OFC 
60.5 cm (+4SD). Hand and feet were narrow with long fingers and toes, overriding 
toes and bilateral ankylosis of the metacarpophalangeal joint of thumb. He had flat 
feet with dystrophic nails. He had long and expressionless face, malar hypoplasia, 
short palpebrale fissures, small and open mouth with drooling, high-arched-palate 
and enamel defect. He had slender build and distal amyotrophy. Speech was limited 
with simple sentences, severe elocution disability and nasal speech. Extensive 
metabolic screening was normal. Myotonic dystrophy and fragile X were excluded. 
Brain MRI demonstrated bilateral megalencephaly, a thick corpus callosum, enlarged 
white matter, septum pellucidum cyst, and a small cerebellum. High resolution 
cytogenetic studies (array CGH) identified a de novo 15q13.3 deletion. 
Case MCCID2, a male, is the first child of healthy, non consanguineous parents with 
no medical family history of note. He has 3 healthy younger sisters (Figure 1A). 
Because hydramnios and short long bones were noted in the 2nd trimester of 
pregnancy, amniocentesis was performed and karyotyping showed normal 
chromosomes, 46,XY. He was born at 37.6 WG with low birth parameters (BW: 2540 
g, BL: 46 cm, OFC: 35.5 cm) and an Apgar score of 10/10. He presented poor 
sucking, gastrointestinal reflux, stridor, cryptorchidism and hypotonia from birth. He 
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developed convergent strabismus within the first year of age. Motor skills have been 
delayed with head control achieved at 10 months and walking unaided at 3 years of 
age. At that time language was limited to a few single words. He was slender built 
and macrocephalic with weight and height on -2 SD and head circumference on +2 
SD. His thorax was long and narrow and he developed kyphoscoliosis and pes 
planus. He was awkward and slow with weak patella reflexes. He suffered from 
drooling, persistent deglutition difficulties and severe elocution disability with nasal 
speech. He could not blow or smack. He had multiple dental caries due to mouth 
breathing. Chronic otitis media resulted in conductive hearing loss of 40 to 60 dB and 
has been treated with grommets. Hands and feet were narrow with overriding toes 
and ankylosis of the metacarpophalangeal joint of both thumbs. Although 
macrocephalic, his forehead was relatively short and narrow with low frontal and 
temporal hairline. The face was elongated with upslanting palpebral features, a 
convergent squint, a thin and high nasal root with deviated nasal septum and large 
tip with short columella, severe malar hypoplasia, a small open mouth with narrow 
and high palate, narrow dental arcades and crowding of teeth. Ears were normally 
placed and folded with hypoplastic ear lobes. He made constant progress, was toilet 
trained at about 7 years, speaks in sentences and is able to write his name and read 
simple words. He has a shy, gentle and cheerful behaviour. When last seen at 15 
years of age, puberty was delayed and orthopaedic surgery of the kyphoscoliosis 
was planed.  
Brain MRI performed at 18 months and 8 years showed a thick corpus callosum, 
asymmetric trigone and lateral ventricles and a Chiari malformation type I (Figure 
1B). EEG showed no gross anomaly. Extensive metabolic screening was normal. 
Skeletal X-rays showed no malformation of the vertebrae. CytoChipTM (BlueGnome, 
Cambridge) array-CGH did not detect any copy number variant.  
 
Whole-exome sequencing 
 
Agilent SureSelect librairies were prepared from 3 µg of genomic DNA sheared with 
a Covaris S2 Ultrasonicator as recommended by the manufacturer. Exome capture 
was performed with the 50 Mb SureSelect Human All Exon kit (Agilent technologies) 
using a multiplex approach with molecular barcodes for traceable ID of samples. 
Sequencing was carried with the SOLiD5500 (Life Technologies) on a pool of 
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barcoded exome librairies. 75+35 paired-end reads were generated and mapped on 
human genome reference (NCBI build37/hg19 version) using LifeScope (Life 
Technologies). 
Sequences produced allowed a mean sequence coverage of 42-87 reads per bp. 
The average coverage was 70X, with more than 75% of targeted bases covered 15X. 
Sequence reads were aligned to the human reference genome sequence (assembly 
GRCh37) using Mapreads. SNPs/indels were called using Genome analysis toolkit 
and Picard tools. Poorly mapped (less than 3X cover) and low-quality reads (less 
than 20 quality score) were removed. An in-house software (PolyWeb) was used to 
annotate and filter the variants. 
 
Mice 
 
Generation of Nonogt mice was described previously (29). Mice have been 
backcrossed greater than 12 generations to C57/Bl6J. All experiments were 
performed by comparing adult wild type and mutant littermates (2-3 months old). 
Animal housing and experimental procedures are in agreement with veterinary law of 
the canton of Zurich. 
 
CT and MR Scanning and analysis 
 
The skulls of 20 mice per genotype were scanned with in vivo 3D micro computed 
tomography (Quantum Fx, Perkin Elmer, Waltham MA). All mice were sacrificed prior 
to scanning and placed in the micro CT in ventral recumbency with the head 
centered to the field of view. Scans were taken with an isotropic voxel resolution of 
59 µm. The protocol used 90 kV and 100 µA with 50 msec per projection resulting in 
a total scan time of 3 minutes for 360°. 3D surface reconstructions of all skulls were 
created using the Quantum Fx viewer and assessed/scored for signs of deformation 
and morphological anormalies by two independent investigators. Analysis of skull 
parameters was done as described in (30). Micro MR images were acquired as 
described in (31) via high-resolution MRI of mouse brain at 9.4T using a cryogenic 
quadrature transceiver coil. (Inplane image resolution 60x60mm2). 
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Mouse Behavioral Experiments 
 
STATISTICAL MODELS: Data were analyzed using mixed ANOVA models with 
genotype (KO, WT) as between-subject factor. Within-subject factors were added as 
needed to explore the dependence of genotype effects on place, time, or stimulus. 
Significant interactions and, where necessary, significant main effects were further 
explored by Tukey-Kramer post-hoc tests or by splitting the ANOVA model, as 
appropriate. One-sample t-tests were used for follow-up comparisons against chance 
levels. Variables known to produce strongly skewed distributions and/or frequent 
outliers were subjected to a log transformation before ANOVA analysis (as indicated, 
e.g. latency measures). The significance threshold was set at 0.05. The false 
discovery rate (FDR) control procedure of Hochberg was applied to groups of 
conceptually related variables within single tests to correct significance thresholds for 
multiple comparisons. 
 
Prepulse Inhibition: The session consists of a series of six 40-ms startling pulses of 
different intensities varying between 100 and 120 dB in order to get an average 
magnitude of the initial animal’s startle response. The animal is then subjected to a 
succession of 6 discrete trials. Each trial includes a short period of background white 
noise (control no- stimulus condition), followed by 20-ms pre-pulses (4, 8, 12, 16, and 
20 decibels above the background white noise) and 40-ms startling pulses (100 to 
120 dB) presented either separately or in combination (pre-pulse + pulse, with a 
delay of 100 ms between the two stimuli). The session is completed with additional 
six 40-ms startling pulses and background noise. The time interval between two 
stimulus presentations can vary between 10 and 20 seconds. 
 
Elevated plus maze: The apparatus is a crossbar-shape maze, comprising two 
symmetrically arranged open arms equipped with 3-mm ledges and two closed arms 
equipped with 20-cm walls. The intersection of the 4 arms forms a small central zone 
(5 cm x 5 cm). The maze is elevated 38 cm from the ground. The whole apparatus is 
made of semi-transparent Plexiglas. The mouse is put on the central platform, the 
head facing a closed arm. The session lasts 5 min, starting once it enters the four 
paws in to one arm, whichever close or open. The behavioral parameters are 
recorded on-line. 
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Open-field Test: The large open-field arena is circular with a diameter of 150 cm, a 
white plastic floor, and 35 cm high sidewalls made of white polypropylene. 
Illumination is by indirect diffuse room light (4 40W bulbs, 12 lux). Each subject is 
released near the wall and observed for 10 min. The same procedure is repeated the 
following day, resulting in a total observation time of 20 min. Movements are tracked 
using Noldus EthoVision. The number of deposited fecal boli is recorded after each 
session. 
 
Light-Dark box: A 20x30 cm lit chamber with transparent Perspex walls (20 cm 
high) and open top is connected to a 20x15x20 cm polyvinyl-chloride box. The box is 
dark (ca. 10 lux) and completely enclosed, except for the 7.5x7.5 cm opening 
connecting it to the lit chamber. The lit chamber is under direct room light (ca. 450 
lux). Each subject is released in the middle of the lit compartment and observed for 5 
min. Movements are tracked using Noldus EthoVision. Rearings and grooming are 
recorded using the keyboard event-recorder provided by the video-tracking system. 
 
Morris Water Maze: This test was conducted as described previously (32), in ca. 12-
lux light in a 150cm-diameter water pool. Six trials are conducted per day, each 
separated by 30-60min and lasting 2min, either learning (15x15cm platform 0.5cm 
above the water surface), or testing (platform 0.5cm below water surface). Three 
days of acquisition and two days of reversal training are conducted. Movements are 
tracked using Noldus Ethovision. Mouse performance was evaluated using 
Gallagher’s measure of proximity (the average distance away from the goal during 
the test) and Whishaw’s error (% path outside a 18cm wide straight corridor 
connecting release point and goal) (33, 34).  
 
Expression analyses 
 
Total cultured human and mouse skin fibroblast RNAs were isolated using the 
RNeasy Mini Kit (Qiagen). RNA quality was assessed using RNA Nano LabChips 
and the 2100 Bioanalyzer (Agilent Technologies) and RNA concentration was 
measured by spectrophotometry (Nanodrop, Thermo Scientific). Briefly, 100 ng of 
total RNA was reverse transcribed, and second strand DNA was produced and 
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amplified by in vitro transcription in the presence of biotinylated ribonucleotides using 
the IVT Express kit (Affymetrix). Microarray experiments were performed for 2 
controls and 2 patients in duplicate on the Affymetrix Human PrimeView Arrays (a 
genome wide array with 49293 probe sets), hybridized with fragmented amplified 
RNA as recommended by the manufacturer. Similarly, mouse RNAs from 2 Nonogt 
and 2 WT mice were hybridized on Affymetrix GeneChip® Mouse Genome 430 2.0 
Arrays (a genome wide array allowing the analysis of 39,000 transcripts). 
Fluorescence data were imported into two analysis softwares: Affymetrix® 
Expression Console™ and R Bioconductor. Gene expression levels were calculated 
using the RMA algorithm Expression Console and flags were computed using a 
custom algorithm within R [http://www.r-project.org/]. Assuming that a maximum of 
80% of genes are expressed we select the 20% lowest values for each microarray to 
be background expression data measures. We have then computed a threshold at 
two standard deviations over the mean of the background. All probes which 
normalized intensity measures were lower than the computed threshold were flagged 
0 instead of 1. The list has been created filtering probes flagged as 1 for at least half 
of the chips. The group comparisons were done using Student’s t test. To estimate 
the false discovery rate we filtered the resulting p-values at 5% and used the 
Benjamini and Hochberg, Bonferroni or without correction. Cluster analysis was 
performed by hierarchical clustering using the Spearman correlation similarity 
measure and average linkage algorithm.  
Meta-analysis of human and mouse samples types was performed as previously 
described36. 
 
Mouse hippocampal RNAs were extracted using a GenElute Mammalian Total RNA 
Miniprep Kit (Sigma, St Louis, MO, USA) according to the manufacturer's 
instructions. Total RNA was quantified by absorbance spectroscopy and RNA 
integrity and quality was assessed by 1.0% agarose gel electrophoresis. Total RNA 
(1 µg) was transcribed to cDNA with SuperScript II (Invitrogen, Carlsbad, CA, USA) 
using random hexamer primers according to the manufacturer's instructions.  
For quantitative real-time PCR (qPCR), 20 ng of cDNA was used, and single 
transcript levels of genes were detected with the HOT FIREPol EvaGreen qPCR Mix 
(Solis BioDyne, Tartu, Estonia) and an AB7900 thermocycler. Primers used for 
detection of synaptic transcripts were as follows: 
& & Results&
! 79&
 
βUActin&Fwd& AGTGTGACGTTGACATCCGTA&
βUActin&Rev& GCCAGAGCAGTAATCTCCTTCT&
GABRA1&Fwd& GGTTGACCGTGAGAGCTGAA&
GABRA1&Rev& CTACAACCACTGAACGGGCT&
GABRA2&Fwd& CAGTGGCCCATAACATGACAAT&
GABRA2&Rev& GGACATTCGGCTTGGACTGT&
Gephyrin&Fwd& GGCGACCGAGGGAATGAT&
Gephyrin&Rev& CCACCCAACAAAGAAGGATCTT&
CamK2a&Fwd& CCCCTTTCGCCTACATGTGA&
CamK2a&Rev& GGCTACAGTGGAGCGGCTTA&
 
Data were analyzed using the comparative CT method (Schmittgen & Livak, 2008). 
 
For transcriptome analysis using RNA-Seq, the quality of the isolated RNA was 
determined with a Qubit® (1.0) Fluorometer (Life Technologies, California, USA) and 
a Bioanalyzer 2100 (Agilent, Waldbronn, Germany). RNAs were then processed 
using The TruSeq Stranded mRNA Sample Prep Kit (Illumina, Inc, California, USA) 
according to the manufacturer recommendations. The TruSeq SR Cluster Kit v3-
cBot-HS or TruSeq PE Cluster Kit v3-cBot-HS (Illumina, Inc, California, USA) was 
used for cluster generation using 8 pM of pooled normalized libraries on the cBOT. 
Sequencing was performed on a Illumina HiSeq 2000 system using the TruSeq SBS 
Kit v3-HS (Illumina, Inc, California, USA) with paired end 2 X100 reads or single end 
1X100 reads. 
 
RNA-seq reads were quality-checked with fastqc which computes various quality 
metrics for the raw reads. Reads were aligned to the genome and transcriptome with 
tophat v 1.3.3. Before mapping the low quality ends of the reads were clipped (3 
bases from the read start and 10 bases from the read end). Tophat was run with 
default options. The fragment length parameter was set to 100 bases with a standard 
deviation of 100 bases. Based on these alignments the distribution of the reads 
across genomic features was assessed.Isoform expression was quantified with the 
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RSEM algorithm (http://www.biomedcentral.com/1471-2105/12/323) with the option 
for estimation of the read start position distribution turned on. 
 
Meta-analysis of human and mouse samples types was performed as previously 
described (35). 
 
Cell culture and transfection 
 
Human primary fibroblasts were cultured at 37°C under 5% CO2 in RPMI® + 
glutamax or OPTI-MEM® + glutamax supplemented with 10% of fetal bovine serum 
(FBS) and 5% of penicillin/streptomycin (complete medium) (Life Technologies).  
 
Mouse primary hippocampal neuron cultures were prepared as described previously 
(36). Hippocampal cultures were transfected with 0.5 µg of either eGFP–gephyrin or 
the specific myc–NONO construct according to the protocol described previously 
(36). Cells were transfected after 8 DIV and processed for immunofluorescence 7 
days later (referred to as 8+7 DIV). In co-transfection experiments the total DNA 
concentration was maintained at 1.5 µg. 
 
Plasmids used for transfection 
 
The eGFP–gephyrin P1 variant has been described previously (37). Overexpression 
of myc-NONO and myc-NONO RRM, were conducted using the plasmids described 
in (38). GABRA2 was created amplifying rat cDNA by primers containing HindIII and 
XhoI sites and subsequent cloning into the pCR3.1 vector. 
 
Western blot  
 
Human primary fibroblasts protein extracts were prepared on ice in lysis buffer (50 
mM Tris pH 8, 170 mM NaCl, 0.5% NP-40 X-100, 50 mM NaF, and Complete EDTA-
free protease inhibitor 11697498001, Roche Applied Science). The Bradford protein 
assay was used to determine the concentration of each sample (B6916-500 Sigma). 
20-30µg of protein extracts were separated by 4-20% SDS-PAGE (SDS-PAGE Mini-
PROTEAN® TGX Stain Free™ #4568093 Biorad). Stain Free gels were exposed to 
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UV light for 2’30” prior to transfer to 0.2 µm nitrocellulose membranes (Trans-Blot 
Turbo Transfer Pack #1704158 Biorad). UV-induced fluorescence corresponding to 
total proteins were first visualized with ChemiDoc MP imaging system, then blocked 
with 5% nonfat dried milk powder (Invitrogen) diluted in PBS-T (1XPBS with 0.2% 
Tween-20) for 1-2H and incubated overnight at 4°C in 2% milk in PBS-T with the 
primary antibodies: NONO, SFPQ, PSPC1, and β-actin used as a control for protein 
loading. Membranes were then incubated with horseradish peroxidase–conjugated 
secondary antibodies.! Proteins were visualized using ECL-Plus (GE Healthcare). 
Various exposure times were performed for either autoradiography films and AGFA 
development (Curix 60 n°1829) or Chemidoc system (Biorad). Raw signal intensities 
were first obtained for target proteins as well as total proteins profile, with the same 
sample as reference, using volume tools in the ImageLab software (Biorad). 
Background signal was deducted from each value. Final quantification data were 
given as a ratio of target signal to total signal. 
Mouse brain lysate and sample preparation were performed as described40. Each 
lane was loaded with 50 µg protein and after blotting, the nitrocellulose membrane 
was directly blocked for 30 min with 1% solution of Western Blocking Reagent 
(Roche Applied Science, Indianapolis, US).  
 
Antibodies 
 
The following antibodies were used: Human Antibodies: mouse anti-β-actin (AM4302, 
1:20,000; Ambion), rabbit anti-NONO (LS-C31127, 1:2,000; LSBio Cliniscience), 
rabbit anti-SFPQ (A301-320A, Bethyl), mouse anti-PSPC1 (sc-374181, 1:1,000; 
Santa Cruz), Mouse anti-gephyrin antibody (mAb7a, 1:3000; or 3B11, 1:10000; 
Synaptic Systems, Gottingen, Germany), rabbit anti-vGAT antibody (1:3000, 
Synaptic Systems, Gottingen, Germany), guinea pig anti-GABAAR α2 subunit 
antibody41, mouse anti-Myc (1:10000, Roche), rabbit anti-NONO (1:500, (40)), rabbit 
anti-PSPC1 (1:500, (40)). rabbit anti-SFPQ (1:500, (40)), NeuN (MAB377, Milipore), 
GFAP (Z0334, DAKO and MAB360, Millipore), PSD-95 (MA1-045, Affinity 
Bioreagents), β-actin (MAB1501, Millipore). Secondary antibodies were Donkey anti-
rabbit IgG-HRP antibody (1:20,000; sc-2313, Santa Cruz) or donkey anti-mouse IgG-
HRP antibody (1:20,000; sc-2314, Santa Cruz). 
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Immunocytochemistry and Imaging on human skin fibroblasts  
 
Cells were harvested and seeded one day prior to immunocytochemistry experiment 
with equal cell density for each well. 24H later, cells were rinsed twice in PBS and 
fixed in IC fixation buffer (FB001 Invitrogen) for 10 minutes at room temperature. 
Cells were then permeabilized with 0.5% Triton X-100 for 10 minutes at room 
temperature. After 3 PBS washes, blocking was done with 5% BSA diluted in 0.1% 
Triton-PBS for 30 minutes at room temperature. Hybridization was performed with 
the first antibodies used in Western blotting experiments in a moist chamber 
overnight at 4°C. After 3 x 10 minutes 0.1% Triton-PBS washes, the following 
detections were carried out with secondary antibodies Alexa488 anti-rabbit IgG 
(1:400, A-11034, Life Technologies) and Alexa594 anti-mouse IgG (1:400, A-11005, 
Life Technologies) for 1H at room temperature in a dark and moist chamber. After 3 x 
10 minutes 0.1% Triton-PBS washes and a final PBS wash, slides were mounted 
with ProLong (P36935, Invitrogen). Images were taken with a Zeiss LSM700 
microscope fitted with a Plan-Apochromat 40x/1.3 Oil DIC M27 objectif and the Zen 
2009 software. Images montage was done using ImageJ. 
 
Immunocytochemistry and immunohistochemistry on mouse samples 
 
Immunocytochemistry was performed as described previously (41). In short, cells 
were rinsed in PBS and fixed for 10 minutes in 4% paraformaldehyde at room 
temperature. Cells were permeabilized with 0.01% Triton X-100 and detection of 
intracellular proteins were achieved by incubation for 60 minutes at room 
temperature with primary antibodies diluted in PBS containing 10% normal serum, 
followed by incubation with secondary antibodies coupled to Cy3 or Cy5 (1:500, 
Jackson ImmunoResearch) for 30 minutes at room temperature. Finally, coverslips 
were mounted with fluorescent mounting medium (Dako Cytomation, Carpinteria, 
CA). The GABAARα2 subunit antibody was incubated in living cultures for 90 
minutes in culture medium (42). 
Staining and immunhistochemical analysis of synaptic components was performed 
as previously described (43). Briefly, mice were anesthetized with pentobarbital and 
perfused intracardially with ice-cold, oxygenated ACSF. The brain was extracted and 
cut in blocks containing the regions of interest for analysis (e.g. hippocampal 
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formation). The Tissue was plunged into ice-cold, freshly prepared fixative (4% PFA 
in PBS) and postfixed for 90 min, rinsed with phosphate-buffered saline (PBS), 
cryoprotected overnight in 30% sucrose in PBS and frozen with powdered dry ice 
and stored at –80 °C. 
Sections were cut from frozen blocks with a sliding microtome at a thickness of 
40 µm and were collected free-floating in PBS. They were incubated under 
continuous agitation in primary solution (Tris buffer (pH 7.4) containing 0.2 Triton X-
100, 2% normal serum and the primary antibodies) for 15–48 h at 4 °C, washed in 
Tris buffer and incubated for 30–60 min at room temperature in secondary antibodies 
coupled to a fluorochrome. 
Immunofluorescence images were captured by laser scanning confocal microscopy, 
using a 20x, 40x or 64x lens respectively (NA 1.4, 1024 x 1024 pixels, Zeiss LSM 
710). Final illustrations were prepared from the maximal intensity projection of stacks 
of images spaced at 0.5 µm. Signals were quantified, using a custom macro created 
with the ImageJ software. Images were back- ground-subtracted and filtered with a 
Gaussian filter, but no change in brightness and contrast was applied.  
 
High-resolution in-situ hybridization 
 
Dissociated hippocampal neurons were prepared and maintained as previously 
described (41). In situ hybridization was performed using the QuantiGene (QG) 
ViewRNA kit from Panomics as previously described with the following modifications. 
Cells (DIV 14) were incubated for 2 min at room temperature in PBS and fixed for 15 
min using 4% formaldehyde solution (in PBS pH 7.4). After fixation, cells were 
permeabilized using a detergent solution (Panomics) for 5 min. Cells were washed 
three times with PBS followed it with in situ hybridization using GABRA2 and pan 
collybistin (Arhgef9) probes designed by Panomics, following the manufacturer’s 
instructions. Briefly, probes were diluted 1:100 in hybridization buffer supplied by 
Panomics, incubated at 40°C (3hr), washed, hybridized with preamplification 
oligonucleotides (1:100) at 40°C (40 min), washed, hybridized with amplification 
oligos (1:100) at 40°C (40 min), washed, and finally hybridized with the label oligos 
(1:100) at 40° C (40 min). Cover-slips were dried at RT in vertical position. Coverslips 
were mounted with Dako-DAPI fluorescent mounting Medium (Dako S3023) and left 
to polymerize overnight at 4°C. 
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Synaptosome preparation  
 
Synaptosomes have been prepared as described in (44). In brief, mouse brains were 
homogenized in 5 ml homogenization buffer (0.32 M sucrose, 1 mM EDTA pH 7.4, 1 
mM dithiothreitol, phenylmethanesulfonyl fluoride solution (Sigma, 93482-50ML-F), 
complete mini-protease inhibitor (Roche Diagnostics) for 10 sec using a polytron. The 
homogenate was centrifuged at 1,000g for 10 min at 4 °C yielding the nuclear 
fraction (Nuc) and the supernatant (Sup). The supernatant was centrifuged at 
31,000g for 5 min at 4°C using a discontinuous Percoll gradient. The layer between 
3% and 10% of Percoll were collected, washed in 30 ml of homogenization buffer 
and further centrifuged at 22,000 × g for 15 min at 4°CT. The pellet was resuspended 
in in EBC buffer (50 mM Tris-HCl pH 8.0, 120 mM NaCl and 0.5% NP-40) containing 
complete mini-protease inhibitor (Roche Diagnostics) and phosphatase inhibitor 
cocktail 1 and 2 (Sigma–Aldrich)) for Western blot analysis or lysis buffer for RNA 
extraction (GenElute Mammalian Total RNA Miniprep Kit, Sigma). 
 
Circadian analysis of patient fibroblasts.  
Analysis of circadian clock function in dermal fibroblasts from patients and controls 
was performed exactly as described in (45). In brief, dermal fibroblasts were infected 
with the pBluFpuro lentivirus, containing a circadian reporter consisting of the human 
Bmal1 promoter driving expression of luciferase. After selection, identical plates of 
cells were grown, and their circadian clocks were synchronized with the hormone 
dexamethasone. Subsequently, bioluminescence in each plate of cells was 
monitored by real-time bioluminescence for five days in a custom-constructed 
luminometer. Data were detrended by subtraction of a 24-hour running average, and 
period length and amplitude were calculated using the Lumicycle Analysis software 
package (Actimetrics). 
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SUPPLEMENTARY INFORMATION 
 
 
 
Supplementary Figure 1. Molecular analyses of patients MCCID1 and MCCID2. 
(a) Sanger sequencing chromatograms showing the NONO mutations in the 
probands and their parents. (b) Schematic representation of the NONO transcript 
showing exon structure. (c) Schematic overview of the NONO protein showing the 
different functional domains. 
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Supplementary Figure 2. Reduced circadian amplitude in patient fibroblasts. (a) 
Graph of average circadian oscillations of bioluminescence from Bmal1-luciferase 
reporter-infected fibroblasts from patients (grey) or siblings (black). Y-axis, 
background-subtracted bioluminescence in photons per minute; X-axis, time in days. 
Depicted curve is the average of three independent experiments in technical 
quadruplicate. (b) Circadian period measured in cells from controls (black bars) and 
patients (open bars). (c) Circadian amplitude measured in the same cells (arbitrary 
units). Student t-test, p<0.001. Values for both panels are the average of three 
independent experiments with fibroblasts from both patients and their siblings in 
technical quadruplicate. 
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Supplementary Figure 3. Brain morphology in Nonogt mice. (a) Photograph of 
representative brains from WT (left) and Nonogt (right) mice. (b) Quantification of 
weight of whole brain, cortex, and cerebellum. N=5-9 mice per genotype. Student t-
test. White bars, WT. Black bars, Nonogt. In this and subsequent figures, *** p<0.001, 
** p<0.01, * p<0.05. Quantification of all brain parameters from different 
morphological tests is shown in detail in Supplementary Table 4. 
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Supplementary Figure 4. Anxiety-related phenotypes in Nonogt mice. (a) 
Percentage of time spent in open arms of elevated plus-maze. N=13-14 mice per 
genotype. Student t-test, p<0.001 (b) Post-conditioning startle response in prepulse 
inhibition test. Y-axis, whole-body startle response in volts; X-axis, stimulus in 
decibels. N=13-14 mice per genotype. Student t-test, p<0.01 or 0.001 as indicated. 
(c) Open-field exploration. Y-axis, percentage of area surface tiles visited. X-axis, 
subsequent 5-minute intervals after commencement of test. N=18 mice per 
genotype, repeated ANOVA, gene p<.0002, time p<.0001, time x gene n.s. (d) Light-
dark transition test. Y-axis, percentage of time spent in zones indicated on X-axis. 
N=18 mice per genotype, repeated ANOVA, gene p<.0001, zone p<.0001, zone x 
gene p<0.0001. In all panels, Nonogt mice are represented by black bars/circles, 
compared to WT littermates (open). 
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Supplementary Figure 5. Cell type and layer-specific localization of NONO in 
mouse brain. (a) Staining of hippocampal cell nuclei by DAPI (blue), anti-NONO 
(green), and neuron-specific anti-NeuN or astrocyte-specific anti-GFAP (red, left or 
right column respectively). (b) Identical staining of cortex. 
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Supplementary Figure 6. Widespread dysregulation of transcription in Nonogt 
mice hippocampi. (a) Volcano plot of deregulated genes. Red dots, p<0.01 and 
log2>0.5. (b) Reduced GABRA2 protein levels in hippocampi of Nonogt mice. White 
bars, WT. Black bars, Nonogt. Student t-test, N=4. (c) List of most severely 
deregulated transcripts, showing upregulation of sister DBHS family members Sfpq 
and Pspc1. The full dataset is available as GEO Accession number XXX. 
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c Identifier) Description) log2)Ratio) pValue) fdr)
Nono$ non%POU%domain%containing,$octamer$binding$protein$[Source:MGI$Symbol;Acc:MGI:1855692]$ %9.238$ 0$ 0$
2900052N01Rik$
$ $
%0.6108$ 2.99E%09$ 2.26E%05$
Upp2$ uridine$phosphorylase$2$[Source:MGI$Symbol;Acc:MGI:1923904]$ %1.281$ 7.45E%09$ 3.75E%05$
Bmper$ BMP%binding$endothelial$regulator$[Source:MGI$Symbol;Acc:MGI:1920480]$ 0.667$ 3.19E%07$ 0.001204$
Gm14420$ predicted$gene$14420$[Source:MGI$Symbol;Acc:MGI:3652255]$ %0.4389$ 5.07E%07$ 0.001532$
Gpc5$ glypican$5$[Source:MGI$Symbol;Acc:MGI:1194894]$ %0.4365$ 7.32E%07$ 0.001842$
S100b$ S100$protein,$beta$polypeptide,$neural$[Source:MGI$Symbol;Acc:MGI:98217]$ %0.4118$ 1.24E%06$ 0.002607$
Gm14436$
$ $
%0.5737$ 1.41E%06$ 0.002607$
Gm20605$ predicted$gene$20605$[Source:MGI$Symbol;Acc:MGI:5306917]$ %0.5245$ 1.55E%06$ 0.002607$
Pcdhga2$
$ $
%0.8458$ 1.98E%06$ 0.002991$
Fam70b$
$ $
1.166$ 4.80E%06$ 0.00658$
Pspc1$ paraspeckle$protein$1$[Source:MGI$Symbol;Acc:MGI:1913895]$ 0.3825$ 5.29E%06$ 0.006655$
Ndrg2$ N%myc$downstream$regulated$gene$2$[Source:MGI$Symbol;Acc:MGI:1352498]$ %0.3416$ 6.94E%06$ 0.008061$
Gm14295$ predicted$gene$14295$[Source:MGI$Symbol;Acc:MGI:3709624]$ %0.5034$ 8.28E%06$ 0.008928$
Sfpq$ splicing$factor$proline/glutamine$rich$[Source:MGI$Symbol;Acc:MGI:1918764]$ 0.3559$ 1.34E%05$ 0.01349$
Cst3$ cystatin$C$[Source:MGI$Symbol;Acc:MGI:102519]$ %0.3788$ 1.90E%05$ 0.017$
Tnfrsf25$ tumor$necrosis$factor$receptor$superfamily,$member$25$[Source:MGI$Symbol;Acc:MGI:1934667]$ %0.7091$ 1.91E%05$ 0.017$
Cnga4$ cyclic$nucleotide$gated$channel$alpha$4$[Source:MGI$Symbol;Acc:MGI:2664099]$ %1.523$ 2.06E%05$ 0.01723$
Rbm14$ RNA$binding$motif$protein$14$[Source:MGI$Symbol;Acc:MGI:1929092]$ 0.3552$ 3.22E%05$ 0.02561$
Gabra2$ gamma%aminobutyric$acid$(GABA)$A$receptor,$subunit$alpha$2$[Source:MGI$Symbol;Acc:MGI:95614]$ %0.3623$ 3.47E%05$ 0.02622$
Magt1$ magnesium$transporter$1$[Source:MGI$Symbol;Acc:MGI:1914325]$ 0.4012$ 3.99E%05$ 0.02865$!
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Supplementary Figure 7. Overexpression of PSPC1 and SFPQ protein in in 
Nonogt mice hippocampi. (a) Western blots of hippocampal protein extracts from 
widtype and Nonogt mice hippocampi, probed with anti-NONO, anti-PSPC1, anti-
SFPQ, and anti-β-actin. N=3 mice per genotype. (b) Quantification of (A). White bars, 
WT. Black bars, Nonogt. Student t-test, p<0.01. 
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Supplementary Figure 8. Transcript abundance in different neuronal 
compartments in Nonogt mice. (a) Profile of the mouse forebrain synaptic 
transcriptome. Y-axis, ratio of transcript reads from synaptome RNA sequencing 
compared to total. Selected transcripts previously characterized to be transported to 
synapses (Kif5a, Shank3, CamK2A, Arc, Gabra2), present throughout the cell (Map2, 
Actb), or retained in the nucleus (Neat1) are indicated to demonstrate the quality of 
synaptosomal transcript enrichment. Blue shading, transcripts more than 1.5x 
enriched. (b) Quantification of Neat1 compared to Gapdh in whole-cell homogenate, 
purified nuclei, supernatant, or gradient-purified synaptosomes from WT (white bars) 
or Nonogt mice (solid bars). (c) Quantification of CamkII compared to Gapdh. (d) 
Quantification of Gabra2 compared to Gapdh.  
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Supplementary Figure 9. Reduction of synaptic GABRA2 in Nonogt mice. (a) 
Western blot showing fractionation of mouse forebrain into different neuronal 
compartments by density gradient centrifugation. Immunohistochemistry using 
antibodies against NONO, gephyrin, and GABA is pictured. As a control, β-actin and 
dendrite-enriched PSD-95 are also shown. (b) Quantification of the reduction in 
GABRA2 levels in each compartment. 
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Supplementary Figure 10. Specific reduction of Gabra2 transcript levels in 
cultured Nonogt neurons. (a) Single-transcript-resolution RNA in-situ hybridization 
to detect abundance of collybistin (CB, blue), Gabra1 (blue), Gabra2 (red), and 
CamKII (red) in WT or Nonogt neurons. Two transcripts were tested in different colors 
in a single plate of cells, and depicted in a single column. (b) Quantification of 
collybistin transcript distribution in puncta number per cell for 44-56 cells from 2 
experiments. (C) Similar quantification of Gabra2. Solid circles, Nonogt neurons; open 
circles, WT. 
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Supplementary Table 1: Clinical characteristics of patients with NONO 
mutations 
 MCCID1 MCCID2 
Antenatal findings - hydramnios 
Term born 41 WG WG 
Birth parameters (BW, BL and OFC in 
grammes and cm) 
3370 g, 50.5 cm, 34 cm  2540 g, 46 cm, 35.5 cm  
Neonatal history - poor sucking, GR, hypotonia 
Motor skills walked at 3 y walked at 3 y 
Language short sentences  short sentences 
Nasal speach  ++  ++ 
Elocution disability  + (severe)  + (severe) 
Drooling   +   +  
ID   +  + 
Epilepsy   + (5 years)  - 
Ophthalmologic findings convergent strabismus, myopia convergent strabismus 
Behaviour  shy, gentle and cheerful  shy, gentle and cheerful  
Sleep disorder -  - 
Age at examination  17 y  15 y 
Growth parameters (W, H and OFS in 
SD) 
-1.5SD, + 1SD, +4SD)   -2 SD, -2 SD, +2SD  
Puberty - delayed 
Slender built   +   +  
Scoliosis   +  +++  
   
Arachnodactyly  +   - 
MCP joint ankylosis of P1  + (bilateral)  + (bilateral) 
Pes planus   ++  ++ 
Facial features   
Long face   +  + 
Palpebral fissures  up slanting  up slanting 
Malar hypoplasia  ++  ++ 
Nose Thin and high nasal root, 
deviated nasal septum 
Thin and high nasal root, 
deviated nasal septum 
Mouth   open  small and open 
Palate narrow and high arched narrow and high arched 
Teeth crowding crowding and dental caries 
EEG Abnormal No gross anomaly 
Brain MRI   
Corpus callosum Thick (+ cyst of the septum 
pellucidum) 
 Thick 
ventricles  nl asymmetric lateral ventricles 
Cerebellum  hypoplastic Chiari malformation type I  
Abbreviations are as follows:  
WG : weeks of gestation; BW : birth weight; BL : birth length, OFC : occipitofrontal 
circumference, W : weight, H, heigth, y : year, SD : standard deviation; ID : 
intellectual deficiency, nl : normal, GR : gastro-oesophageal reflux, -: absent, +: 
present 
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Supplementary Table 2 :+Number of variants identified by whole-exome 
sequencing 
 
Patients( MCCID1( MCCID2(
Total&variants& 64010& 71478&
Novel&or&rare&variants&(dbSNP130/1000GP/EVS/inUhouse&database)& 1022& 1030&
Coding&NonUsynonymous/indel/consensus&SS&variants& 255& 248&
exclusively&novel&variants& 88& 87&
Shared&gene&whose&mutations&coUsegregate&in&the&families&& 1& 1&
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Supplementary Table 3: Differentially regulated transcripts in patients and 
Nono-deficient mice. The full dataset is available from ArrayExpress (accession E-
MTAB-2894 and E-MTAB-2895), 
 
   MCCID1   
NONOgt 
mice  MCCID2   
DE Genes 
Profils 
(MCCID1, 
NONOgt 
mice, 
MCCID2) Full name p-value Fold Delta 
p-
value Fold Delta p-value Fold Delta 
ACTA2 UUU 
Actin, alpha 2, smooth 
muscle, aorta 0,00 2,93 28,06 0,00 34,96 220,94 0,02 2,34 40,08 
BHLHE40 UUU 
basic helix-loop-helix 
family, member e40 0,01 1,81 116,37 0,03 4,28 1309,55 0,01 1,63 90,20 
CNN1 UUU 
calponin 1, basic, smooth 
muscle 0,01 1,62 113,90 0,01 106,91 545,44 0,00 1,53 319,56 
COL11A1 UUU collagen, type XI, alpha 1 0,00 13,89 5906,34 0,00 697,63 4069,19 0,00 9,92 4084,12 
COL12A1 UUU collagen, type XII, alpha 1 0,00 2,06 44,11 0,01 460,70 6067,24 0,00 1,59 24,50 
DKK3 UUU 
dickkopf 3 homolog 
(Xenopus laevis) 0,01 1,52 28,35 0,03 3,36 3000,41 0,01 1,67 235,72 
DLG1 UUU 
discs, large homolog 1 
(Drosophila) 0,00 1,75 31,84 0,01 1,58 660,25 0,00 1,82 35,24 
FST UUU follistatin 0,01 1,61 266,91 0,05 10,45 63,58 0,01 1,60 261,20 
GPC4 UUU glypican 4 0,00 4,85 818,41 0,03 3,68 2496,10 0,00 2,07 226,85 
LMCD1 UUU 
LIM and cysteine-rich 
domains 1 0,01 1,62 73,52 0,00 83,09 479,42 0,03 2,41 828,09 
MEX3B UUU 
mex-3 homolog B (C, 
elegans) 0,01 2,84 171,59 0,02 2,18 322,22 0,04 1,56 51,83 
NCAM1 UUU 
neural cell adhesion 
molecule 1 0,00 4,20 204,70 0,02 6,66 3332,05 0,02 1,69 43,95 
PSPC1 UUU paraspeckle component 1 0,01 2,22 494,70 0,03 2,57 615,45 0,01 2,78 721,39 
RHOJ UUU 
ras homolog family 
member J 0,00 3,91 108,47 0,05 2,76 631,44 0,00 2,28 47,76 
RNF128 UUU 
ring finger protein 128, E3 
ubiquitin protein ligase 0,01 2,01 33,71 0,01 11,57 102,80 0,01 3,24 74,43 
SALL1 UUU sal-like 1 (Drosophila) 0,02 2,81 139,02 0,00 57,88 280,83 0,04 2,46 71,50 
SORBS2 UUU 
sorbin and SH3 domain 
containing 2 0,00 1,79 9,28 0,03 6,09 23,75 0,01 2,19 33,14 
SOX11 UUU 
SRY (sex determining 
region Y)-box 11 0,00 1,74 8,54 0,01 30,78 155,19 0,00 4,28 37,92 
TSHZ2 UUU 
teashirt zinc finger 
homeobox 2 0,01 2,47 89,36 0,02 2,80 10,19 0,04 1,80 48,72 
TWIST2 UUU 
twist homolog 2 
(Drosophila) 0,00 2,14 300,21 0,00 4,50 1279,81 0,00 1,98 259,25 
WISP1 UUU 
WNT1 inducible signaling 
pathway protein 1 0,00 2,40 74,30 0,01 2,21 3716,63 0,01 3,38 125,83 
ABCA5 DDD 
ATP-binding cassette, 
sub-family A (ABC1), 
member 5 0,00 0,41 32,25 0,04 0,25 256,57 0,00 0,59 22,15 
AHR DDD aryl hydrocarbon receptor 0,01 0,40 579,72 0,01 0,57 31,72 0,03 0,56 429,28 
ALCAM DDD 
activated leukocyte cell 
adhesion molecule 0,01 0,41 97,88 0,01 0,25 486,49 0,02 0,39 101,38 
ARHGAP
18 DDD 
Rho GTPase activating 
protein 18 0,00 0,47 796,59 0,00 0,21 1146,53 0,00 0,43 859,15 
CCBE1 DDD 
collagen and calcium 
binding EGF domains 1 0,00 0,25 625,52 0,02 0,18 1406,97 0,00 0,49 420,06 
EBF3 DDD early B-cell factor 3 0,00 0,28 89,36 0,02 0,24 133,74 0,04 0,37 77,64 
GJC1 DDD 
gap junction protein, 
gamma 1, 45kDa 0,03 0,58 510,20 0,02 0,38 853,36 0,05 0,60 138,37 
GLCCI1 DDD 
glucocorticoid induced 
transcript 1 0,03 0,50 85,92 0,01 0,32 177,94 0,02 0,37 107,83 
GLRX DDD 
glutaredoxin 
(thioltransferase) 0,00 0,60 299,02 0,04 0,33 293,86 0,00 0,48 390,86 
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HAS2 DDD hyaluronan synthase 2 0,02 0,62 281,41 0,01 0,32 223,83 0,00 0,44 412,14 
IGF2BP3 DDD 
insulin-like growth factor 2 
mRNA binding protein 3 0,00 0,29 304,67 0,05 0,42 362,53 0,00 0,20 344,29 
MECOM DDD 
MDS1 and EVI1 complex 
locus 0,00 0,55 11,32 0,03 0,49 710,76 0,00 0,63 9,14 
NAV2 DDD neuron navigator 2 0,00 0,58 262,16 0,00 0,20 155,82 0,01 0,56 277,64 
NEGR1 DDD 
neuronal growth regulator 
1 0,01 0,56 231,28 0,01 0,04 105,79 0,03 0,58 219,71 
PTER DDD 
phosphotriesterase 
related 0,00 0,44 157,03 0,00 0,62 262,85 0,01 0,34 42,49 
RDH10 DDD 
retinol dehydrogenase 10 
(all-trans) 0,04 0,59 258,51 0,02 0,45 273,84 0,02 0,39 380,29 
RGS20 DDD 
regulator of G-protein 
signaling 20 0,00 0,43 65,24 0,03 0,11 325,08 0,00 0,64 40,72 
RICTOR DDD 
RPTOR independent 
companion of MTOR, 
complex 2 0,00 0,45 41,60 0,01 0,55 452,22 0,01 0,54 34,98 
TLE1 DDD 
transducin-like enhancer 
of split 1 (E(sp1) homolog, 
Drosophila) 0,00 0,42 66,91 0,02 0,50 265,44 0,01 0,52 56,10 
TRIOBP DDD 
TRIO and F-actin binding 
protein 0,01 0,52 69,16 0,04 0,29 1158,17 0,00 0,46 77,63 
WDR20 DDD WD repeat domain 20 0,00 0,46 99,70 0,02 0,66 60,93 0,00 0,45 102,71 
 
D downregulated; U: upregulated 
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Supplementary Table 4. Quantification of brain morphology in Nonogt 
mice. 
 
& WT&(%)& Stdev& NONO&KO&& Stdev& p&Value&
& & & & & &
Brain&weight& 100.00& 1.88& 85.06& 4.87& p&<&0.0001&
Cortex& 100.00& 2.13& 88.25& 3.69& p&<&0.0001&
Cerebellum& 100.00& 11.27& 75.73& 8.91& p&=&0.0004&&
& & & & & &
Skull&lenght& 100.00& 1.77& 91.56& 4.62& p&=&2.49EU7&
Skull&widht& 100.00& 2.61& 96.85& 6.00& p&=&3.45EU6&
Nose&lenght& 100.00& 3.69& 84.97& 9.06& p&=&6.55EU7&
Relative&nose&
length& 32.47& 0.90& 29.86& 2.67& p&=&0.00019&
Skull&Width/Length& 45.74& 1.06& 48.10& 2.46& p&=&0.00032&
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Supplementary Table 5. Gene ontology localization of proteins identified 
as dysregulated in Nonogt mice. 
 
# Localizations p-value FDR 
1 extracellular&space& 2.809E-13 1.103E-10 
2 extracellular&region&part& 3.250E-13 1.103E-10 
3 extracellular&matrix& 2.233E-11 5.053E-09 
4 extracellular&region& 7.617E-11 1.293E-08 
5 plasma&membrane& 6.585E-10 8.943E-08 
6 cell&periphery& 3.689E-09 4.174E-07 
7 cell&surface& 7.807E-09 7.573E-07 
8 cytoplasmic&part& 2.082E-08 1.767E-06 
9 proteinaceous&extracellular&matrix& 4.814E-08 3.632E-06 
10 organelle& 9.166E-07 6.224E-05 
11 extracellular&matrix&part& 1.813E-06 1.119E-04 
12 vesicle& 3.265E-06 1.848E-04 
13 neuron&part& 4.957E-06 2.589E-04 
14 plasma&membrane&part& 6.855E-06 2.981E-04 
15 neuronal&cell&body& 7.218E-06 2.981E-04 
16 external&side&of&plasma&membrane& 7.241E-06 2.981E-04 
17 basement&membrane& 7.464E-06 2.981E-04 
18 neuron&projection& 8.693E-06 3.279E-04 
19 membrane& 1.022E-05 3.653E-04 
20 membraneUbounded&vesicle& 1.111E-05 3.771E-04 
21 cell&body& 1.958E-05 6.330E-04 
22 cell&projection& 2.556E-05 7.890E-04 
23 intracellular&organelle& 2.726E-05 8.047E-04 
24 extracellular&vesicular&exosome& 3.309E-05 9.362E-04 
25 extracellular&membraneUbounded&organelle& 3.969E-05 1.036E-03 
26 extracellular&organelle& 3.969E-05 1.036E-03 
27 membraneUenclosed&lumen& 5.667E-05 1.425E-03 
28 cell&projection&part& 7.825E-05 1.898E-03 
29 integral&component&of&plasma&membrane& 8.650E-05 2.025E-03 
30 intrinsic&component&of&plasma&membrane& 1.612E-04 3.648E-03 
31 organelle&lumen& 1.755E-04 3.844E-03 
32 dendrite& 2.060E-04 4.372E-03 
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33 pericentriolar&material& 2.329E-04 4.792E-03 
34 basal&lamina& 3.408E-04 6.807E-03 
35 side&of&membrane& 4.723E-04 9.115E-03 
36 protein&complex& 4.833E-04 9.115E-03 
37 haptoglobinUhemoglobin&complex& 5.051E-04 9.270E-03 
38 intracellular&organelle&part& 5.319E-04 9.505E-03 
39 membrane&raft& 5.680E-04 9.730E-03 
40 perinuclear&region&of&cytoplasm& 5.802E-04 9.730E-03 
41 membraneUbounded&organelle& 5.875E-04 9.730E-03 
42 lysosomal&lumen& 6.163E-04 9.964E-03 
43 anchoring&junction& 6.784E-04 1.037E-02 
44 histone&acetyltransferase&complex& 6.835E-04 1.037E-02 
45 macromolecular&complex& 6.872E-04 1.037E-02 
46 nucleoplasm&part& 7.722E-04 1.119E-02 
47 organelle&part& 7.744E-04 1.119E-02 
48 vacuolar&lumen& 9.221E-04 1.304E-02 
49 intracellular&organelle&lumen& 9.534E-04 1.321E-02 
50 lysosome& 9.928E-04 1.322E-02 
51 lytic&vacuole& 9.928E-04 1.322E-02 
52 cytosol& 1.061E-03 1.385E-02 
53 MHC&class&II&protein&complex& 1.163E-03 1.490E-02 
54 perikaryon& 1.266E-03 1.591E-02 
55 collagen&type&I&trimer& 1.421E-03 1.750E-02 
56 protein&acetyltransferase&complex& 1.469E-03 1.750E-02 
57 acetyltransferase&complex& 1.469E-03 1.750E-02 
58 dendritic&spine& 1.582E-03 1.852E-02 
59 paraspeckles& 1.670E-03 1.916E-02 
60 neuron&spine& 1.693E-03 1.916E-02 
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Supplementary Table 6. Quantification of synaptic transcripts in Nonogt 
mice. 
 
Synaptically&enriched&genes& 3668&
Total&expressed&genes& 15393&
& 23.83%&
& &
NONO&regulated&genes& 886&
NONO&regulated&genes&with&synaptic&localization& 270&
& 30.47%&
& &
Chi2&=&11.109,&with&1&degree&of&freedom.&&
P&=&0.0009,&2Utailed& &
 !!
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4. General Discussion  
 
The biological basis of learning and memory is mainly regulated by synaptic 
plasticity through molecular mechanisms known as Long Term Potentiation 
(LTP) and Long Term Depression (LTD) and it has been shown that these 
forms of synaptic modifications require de-novo protein synthesis!(164). Over 
the last decades studies have demonstrated that the underlying protein 
translation in dendrites takes place in a small and localized fashion just next 
to the remodeling synapses by utilizing synaptic mRNA. Several techniques 
such as synaptosmal preparations and microdissections combined with high-
resolution in-situ hybridization have greatly helped to better understand the 
precise local tanscriptome at the synaptic periphery. Changes of mRNA 
localization in the cell are the cause for regulating cell polarity and play a 
crucial role during development! (165). While these mRNA dynamics at the 
synapse have been studied during development over long time periods (166, 
167) or very short periods during synapse activation (168), determination of 
temporal dynamics of synaptic mRNAs over a period of 24h has not been 
investigated so far especially given the fact that learning and memory 
consolidation have been show to be regulated in a circadian fashion (40-42).  
 
The fist part of the thesis focused on the identification of circadian synaptic 
transcpritps in the mosue brain. Transciptomic analysis identified 180 
circadian genes from which only 15.5% showed rhythmicity in total brain 
extracts indicating a mechanism, which mainly is driven independently by the 
circadian transcription of transcripts in the nucleus.  
 
One potential mechanism by which mRNA is regulated at the synapse would 
be the regulation of transcript stability. In mammals, mRNA localization and 
stability is highly regulated by its 3’ untranslated region (UTR), especially by 
shortening of the poly(A) tail. For instance, polyadenylate-binding proteins 
(PABP) associate with the 3’ end of mRNA to regulate polyadenylation and 
preventing the transcript from being degraded and therefore any factors that 
affect the rate of deadenylation will alter the half-life of the mRNA. One 
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recently identified circadian deadenylase and potential target is Nocturnin 
(149). While the role of Nocturnin (Noc) has been extensively studied in 
peripheral processes such as lipid metabolism, adipogenesis, glucose 
homeostasis, inflammation and osteogenesis, however it’s localization and 
role in the brain remains largely unknown. 
 
A possible link between circadian rhythms and spine formation has been 
recently established by the work of Passafaro and coworkers! (169). 
Oligophrenin-1 is a synaptic RhoGTPase-activating protein and it has been 
shown to regulate dendritic spine morpholgoy in the brain (170). Studies of 
patients with X-linked intellectual disability (XLID) have revealed mutations in 
the gene OPHN1 gene, which codes for oligophrenin-1! (171-176). 
Interestingly, it has been found, that oligophrenin-1 and REV-ERBα, a clock 
genes playing a role in stabilizing the circadian rhythm by forming additional 
interlocked feedback loops, interact with each other at the synapse in the 
hippocampus. Overexpression of oligophrenin-1 in primary hippocampal 
neurons lead to the translocation of REV-ERBα to the synapse, while REV-
ERBα localization appeared mainly nuclear upon oligophrenin-1 silencing. 
Furthermore, the author demonstrated, that REV-ERBα translocation is highly 
activity dependent. Pharmacological silencing neuronal transmission by 
tetrodotoxin (TTX) reduced synaptic REV-ERBα levels and blocking GABA 
receptors by the antagonist bicuculline showed a reciprocal effect. The 
synaptic localization of REV-ERBα in bicuculline treated neurons was 
abolished by addition of the AMPA receptor antagonist, suggesting that AMPA 
mediated activation induces REV-ERBα translocation to the synapse through 
oligophrenin-1 (169). By the rhythmicity of REV-ERBα in the hippocampus, a 
circadian synaptic translocation and modulation of the synaptic transcriptome 
might be a potential mechanism, by which the core clock regulates synaptic 
plasticity. 
 
In previous studies, synaptic activity has been shown to initiate the active 
transport of mRNAs from the soma into dendrites by the association of RNA 
binding proteins (RBP) (177-179). Therefore, circadian transport of mRNA 
along the microtubule might be a possible mechanism in generating circadian 
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rhythmicity at the synapse. Given the fact, that the identified transcripts show 
different circadian phase, probably different RNA transport granules might be 
involved at different circadian time points.  
 
An thorough analysis of Kinesin5 (Kif5) associated RNA transport granules by 
gel electrophoresis and subsequent proteome analysis has revealed a total of 
42 proteins (134). The identified transcripts in our study show different 
circadian phase and therefore probably different RNA transport granules 
might be involved at different circadian time points. However, the precise 
composition of individual RNA binding granules has not been well understood 
and it is very likely that specific RNA binding proteins assemble differently at 
certain time points to transport individual mRNA transcripts. 
 
Two of the identified proteins associated with Kif5 RNA transport granules 
were NONO and PSPC1. While the role of NONO and other DBHS proteins in 
transcription and circadian clock regulation is known, its function in synapse 
morphology and function is up to now unclear. In this thesis, we have shown 
that both NONO and PSPC1 modulate inhibitory post-synaptic structures of 
gephyrin and GABAA receptor α2 both in-vitro as well in-vivo using a mouse 
model deficient of the corresponding protein. Interestingly, NONO and PSPC1 
knockout mice exhibit opposite gephyrin and GABAA receptor α2 morphology 
as well GABRA2 mRNA levels. This observation could be explained by two 
models which have been previously described in the literature for the DBHS 
proteins: In the first case, both NONO and PSCP1 compete as negative 
transcription factors with different repressive potentials for GABRA2 
repression, in which NONO would be a weaker repressor compared to 
PSPC1 (113, 118, 158). In a second model, NONO would act as a positive 
transcription factor, while PSPC1 inhibits the transcription of GABRA2 (92, 
115, 120, 159). 
 
In addition, we have shown, that disrupting paraspeckles by depletion of the 
long-noncoding nuclear RNA Neat1 dramatically increases gephyrin and 
GABAA receptor α2 clustering in the mouse hippocampus. Interestingly, it has 
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been recently demonstrated, that nuclear speckles built along the long-
nuclear RNA Malat1 (metastasis associated lung adenocarcinoma transcript 
1) exhibit modulate synapse formation in-vitro (180). DNA microarray studies 
of Malat1 depleted neuroblastoma cells showed, that Malat1 not only 
regulates not only nuclear genes, but particularly genes involved in 
synaptogenesis such as neuroligin 1 (NLGN1) and synaptic cell adhesion 
molecule 1 (SynCAM1). Ultimately, depletion of Malat1 by gene silencing or 
overexpression in primary hippocampal neurons significantly reduced or 
increased synapse density (180). While these findings indicate a novel role for 
long-noncoding RNA’s including Neat1 in synaptogenesis and development, 
the underlying mechanism still remains elusive.  
 
Given the morphological changes in NONO deficient mice in the second part 
of the thesis, we aimed to look in more detail to functional consequences 
upon NONO depletion. We have demonstrated that NONO deficient mice 
exhibit behavioral and craniofacial anomalies as well as global transcriptional 
dysregulation in fibroblasts and hippocampal tissue. This results are strongly 
supported by the finding that null mutations in the NONO gene in humans are 
a novel cause of X-linked syndromic intellectual disability characterized by 
facial features as well as shy, gentle and cheerful behavior (see Study III and 
(181, 182). These findings link NONO to intellectual disability and highlight the 
key role of DBHS proteins in functional organization of GABAergic synapses. 
 
Some of the most pronounced phenotypes in these patients are intellectual. A 
portion of these deficits might arise from effects on neural cell proliferation 
and differentiation, which would be consistent with the transcriptional effects 
that we observe upon genes related to cell growth and proliferation. 
Interestingly, however, in mice proliferative defects arising from NONO 
deficiency are closely linked to circadian clock dysfunction (139), and an 
increasing number of studies have demonstrated that alteration in the 
circadian system affect learning and memory. Therefore, it is possible that 
these symptoms are also linked to the role of DBHS proteins in the circadian 
transcriptional feedback loop. In Drosophila, the circadian clock controls daily 
changes in neuronal and synaptic structure (145-148). In zebrafish, induction 
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and/or formation of long-term memory is modulated by a circadian clock and 
both learning and memory formation occur better during the day than during 
the night (43). In mice, circadian fluctuations are important for learning and 
memory by promoting learning-associated spine formation and elimination 
(66).  
 
In humans, several observations link cognitive disorders to circadian rhythm 
anomalies. Transcriptomic analyses suggest that dysregulation of circadian 
rhythms may be associated to bipolar disorder (183). Low melatonin levels 
have been reported in autism spectrum disorders (54, 55, 142, 143). 
Haploinsufficiency of RAI1 results in the Smith-Magenis syndrome, a disease 
characterized by intellectual disability, multiple congenital anomalies, obesity, 
neurobehavioral abnormalities and a disrupted circadian sleep-wake pattern!
(184). Moreover, RAI1 was recently shown to be a direct regulator of CLOCK, 
a central component of the circadian pacemaker (185). Finally, OPHN1, a 
gene responsible for X-linked ID, is required for normal circadian clock in 
hippocampus (169). Based on these observations we speculate that the 
impaired cognitive development observed in NONO deficient patients might 
be linked to aberrant circadian control of learning-dependent synaptic 
formation and maintenance. Further studies using more relevant cellular and 
animal models will be necessary to elucidate the precise mechanism 
underlying impaired cognitive performance in patients and potentially guide 
treatments. 
 
In conclusion, our data identify NONO as a new neurodevelopmental disease 
gene and further support to the role of DBHS proteins in brain development 
and function. They suggest the existence of a clinically recognizable NONO-
deficiency syndrome characterized by the association of a slender-built 
macrocephaly, thick corpus callosum, severe cognitive impairment and malar 
hypoplasia. Finally, they further argue that altered circadian rhythm may 
contribute to the pathogenesis of intellectual disability. 
 
Deciphering the role of DBHS and paraspeckles in learning and memory will 
provide new insights into the new and unexpected role of this fascinating 
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regulation of RNA biology. 
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6. List of Abbreviations 
 
aCSF Artificial cerebrospinal fluid  
Bmal1 Brain and muscle aryl hydrocarbon receptor nuclear 
translocator (ARNT)-Like  
CaMK  Calmodulin-dependent protein kinase  
CB Collybistin   
CK1 Casein kinase 1 
Clock Circadian locomotor output cycles kaput 
CNS  Central nervous system  
Cry  Cryptochrome  
CT Circadian time 
DBHS  Drosophila Behavior, Human Splicing protein family  
DD  Constant dark 
DG  Dentate Gyrus  
DIV  Days in vitro 
DNA  Deoxyribonucleic acid 
DTT Dithiothreitol  
eGFP  Enhanced Green fluorescent protein 
eIPSC  evoked inhibitory postsynaptic current 
FBS  Fetal bovine serum 
GABA  γ-aminobutyric acid  
GABAAR  GABAA Receptor 
GHT Geniculohypothalamic tract  
GSK3β  Glycogen synthase kinase 3β 
h hours 
KO  Knockout   
lncRNA long Non-coding RNA 
LTD Long-term potentiation  
LTP Long-trm depression  
miRNA micro RNA  
MoCo  Molybdenum cofactor  
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mRNA  Messenger RNA 
ncRNA  Non-coding RNA 
NEAT1  Nuclear enriched abundant transcript 1 
NMDA  N-methyl-D-aspartic acid  
NONO  Non-A POU octamer binding 
p54/nrb 54 kDa nuclear RNA- and DNA-binding protein  
PBS Phosphate buffer saline solution  
PCR  Polymerase chain reaction 
Per1  Period 1  
Per2 Period 2  
Poly(A)  Polyadenylation  
PSD  Postsynaptic density  
PSPC1 paraspeckle component 1 
qPCR  Quantitative PCR 
RHT  Retino hypothalamic tract 
RNA Ribonucleic acid 
RRM  RNA recognition motif 
SCN Suprachiasmatic nucleus 
SFPQ splicing factor proline/glutamine-rich 
vGAT  vesicular GABA transporter  
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